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iAbstract
Substance abuse is an imminent danger on the health of both substance users and non-
users. In general, abuse of psychoactive substances is associated with high risk behaviour,
mortality and morbidity. The drug use cycle involves inextricably intertwined variants
such as production, trading and usage of both licit and illicit addictive substances. The
dynamics of substance use involve initiation, addiction, rehabilitation/treatment and quit-
ting/recovery. In response to supply and abuse of monster drugs, control strategies such
as law enforcement and rehabilitation have been stepped up to reduce access to drugs by
targeting drug kingpins and harm reduction respectively. In this thesis, we model the fac-
tors affecting the prevalence of substance abuse, the effect of drug lords on the prevalence
of substance abuse, and the impact of substance abuse on the prevalence of HIV/AIDS.
We formulate mathematical models based on systems of autonomous differential equa-
tions describing the dynamics of the sub- populations involved in the drug using cycle.
We examine the effects of amelioration, rehabilitation/treatment and re- initiation on the
prevalence of substance abuse. Our results suggest that, recruitment into rehabilitation
and amelioration in the presence of quitting for light users reduce the prevalence of sub-
stance abuse; re-initiation and amelioration without quitting for light users increase the
prevalence of substance abuse. Our assessment of the impact of drug lords and the effect
of law enforcement on drug epidemics shows that, the presence of drug lords seriously
constraints the efforts to reduce substance abuse since they increase access to drugs. How-
ever, law enforcement if stepped up in response to the population of drug lords, greatly
reduces the prevalence of substance abuse. Given the associated influence of drugs on high
risky behaviour, as a cofactor for sexually transmitted infections, we assess the influence of
substance abuse on the prevalence of Human Immunodeficiency Virus (HIV). Our results
show that dissemination of information regarding HIV and drug use reduces HIV preva-
lence whereas, there is faster spread of the epidemic and high prevalence with increased
sexual contact .
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Opsomming
Dwelmmisbruik is ’n dreigende gevaar vir die gesondheid van beide dwelm gebruikers en
nie-gebruikers. In die algemeen, word die misbruik van psigoaktiewe dwelms verbind met
hoë risiko gedrag, mortaliteit en morbiditeit. Die dwelmgebruikskringloop behels onlos-
maaklik vervlegde variante soos vervaardiging, handel en gebruik van beide wettige en
onwettige verslawende middels. Die dinamika van dwelms behels aanvang, verslawing, re-
habilitasie/behandeling en staking/herstel. In reaksie op die misbruik en verskaffing van
monster dwelms, is beheer strategieë soos wetstoepassing en rehabilitasie verskerp, om
die toegang tot dwelms te verminder, deur onderskeidelik te fokus op dwelmspilfigure en
skadebeperking. Die belangrikste doel van hierdie verhandeling is om die faktore te mod-
elleer wat die voorkoms van dwelmmisbruik beïnvloed, die uitwerking van dwelmbase op
die voorkoms van dwelmmisbruik, en die trefkrag van dwelmmisbruik op die voorkoms van
MIV / VIGS. Ons formuleer wiskundige modelle gegrond op stelsels van outonome differ-
ensiaalvergelykings, wat die dinamika beskryf van die sub-bevolkinge wat in die dwelmge-
bruikskringloop betrokke is. Ons ondersoek die effekte van verbetering, rehabilitasie/be-
handeling en heraanvang op die voorkoms van dwelmmisbruik. Ons resultate dui dat,
werwing tot rehabilitasie en verbetering in die teenwoordigheid van stakende tydelike ver-
bruikers, die voorkoms van dwelmmisbruik verminder; heraanvang en verbetering sonder
dat tydelike verbruikers staak, verhoog die voorkoms van dwelmmisbruik. Ons raming van
die invloed van dwelmbase en die uitwerking van wetstoepassing op dwelm-epidemies toon
dat, die teenwoordigheid van dwelmbase belemmer grotendeels die pogings om dwelmmis-
bruik te verminder, aangesien hulle toegang tot dwelms verhoog. Nietemin, as die wet-
stoepassing verskerp word in reaksie op die dwelmbaasbevolking, word die voorkoms van
dwelmmisbruik aansienlik verminder. Gegewe die gepaardgaande invloed van dwelms op
hoë risiko gedrag as ’n kofaktor vir seksueel oordraagbare infeksies, beraam ons die invloed
van dwelmmisbruik op die voorkoms van die Menslike Immunogebreksvirus (MIV). Ons
resultate toon dat inligtingverspreiding rakende MIV en dwelmgebruik, MIV-voorkoms
verlaag, terwyl daar ’n vinniger verspreiding van die epidemie en hoë voorkoms is, met
verhoogde seksuele kontak.
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Chapter 1
Introduction
1.1 Substance Abuse
Substance/drug abuse can be viewed as overindulgence in or dependence on a substance,
drug or other chemical leading to effects that are injurious to the individual’s physical,
social, psychological and mental health and or the welfare of others. Most of the substances
abused are psychoactive substances that lead to dependence syndrome when used.
Definition 1.1.1. Dependence is defined as, “a cluster of cognitive, behavioural, and phys-
iological symptoms indicating that the individual continues the use of the substance despite
significant substance abuse related problems” [106].
Substances abused include both licit (not prohibited by law) and illicit (prohibited by law)
drugs. They can be classified into different classes depending on the level of abuse and
the interest of the classifying organisation. In the case of South Africa [73], substances
abused have been classified into those which are heavily abused, those moderately abused
and those that are less frequently abused. The heavily abused substances include; alcohol
(in all its forms), dagga (cannabis), cigarettes, dagga and mandrax combined, even though
sometimes mandrax (methaqualone) is used on its own. Others in the same category
include prescription drugs such as slimming tablets, tranquillisers and cough mixtures.
Moderately abused substances include; cocaine (cocaine powder), crack- cocaine, heroin,
speed, lysergic acid diethylamide (LSD), hashish, and Ecstasy MDMA. Also in this cate-
gory is methamphetamine which is highly abused in the Western Cape province of South
1
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Africa. Explicit information about health effects, behaviour, law and treatment program
of Methamphetamine is provided in [62]. The least abused substances include; opium,
Rohypnol, ketamine and wellconal.
In the USA, different bodies have classified drugs and the drug abuse disorders into differ-
ent classes. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) divided
the drugs and related disorders into 13 classes based on the drugs abused such as alco-
hol, sedatives, hypnotic or anxiolytic drugs, amphetamines, cocaine, caffeine, cannabis,
hallucinogens (such as LSD) nicotine, opioid, phencyclidine (phenylcyclohexylpiperidine
PCP) . Other bodies classify drugs as follows; the Diagnostic and Statistical Manual of the
American Psychiatric Association, 13 categories, U.S DEA’s and Coast Guard Scheme, 6
categories, Julien Biomedical-Type Scheme into 9 categories, Sussman and Ames Health
Promotion Subjective-Behaviour Scheme into 8 categories [87]. We note that, even though
the classification of substances may differ depending on the classifying body, the substances
abused and the resulting effects are the same.
Drug addiction is a brain disease with well recognised cognitive, behavioural and physio-
logical characteristics that contribute to compulsive and continued use of drugs despite the
harmful consequences. The fact that recovery from drug addiction takes time, and addicts
are at a high risk of relapse, effective rehabilitation programmes are not only required but
also must last long enough to produce stable behavioural change and maintain abstinence
over time. Scientist have also found that chronic drug abuse alters the brain’s anatomy
and chemistry and that these changes last for months or years after the individual has
stopped using drugs. The major example was published by Wolkow et al. [102] on the
lasting changes in the brain and the heart caused by addiction, see Figure 1.1.
The justification of the perplexing and continued abuse of drugs spans basic neurobiological,
physiological, social and environmental factors. According to [102], repeated use of drugs
changes how the brain functions, and affects the natural inhibition and reward centres of
the brain. As a consequence, this results in transition from voluntary to adverse social,
health or legal consequences. Although relapse may be largely due to withdraw symptoms
and stress, craving for drugs may also be as a result of “spontaneous recovery” triggered
by contact with people, places, and things associated with prior drug use.
In-spite of the continued warnings about the drug dependence and health problems asso-
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Figure 1.1. Source [102]: Images of the brain (a) in a healthy control and in an individual
addicted to a drug, and parallel images of the heart (b) in a healthy control and in an
individual with a myocardial infarction. Observe the decreased glucose metabolism in the
orbital frontal Cortex (OFC),(arrow) of the addicted person and a decreased metabolism
in the myocardial tissue (arrow) in the person with myocardial infarct. Damage of the
OFC results in improper inhibitory control and compulsive behaviour, and damage of the
myocardium in improper blood circulation.[For the interpretation of this figure with regard
to colour, the reader is referred to the electronic version]
ciated with drugs, substance abuse has remained more or less equally prevalent. There are
five principle conditions on which large spread, expansion and popularity of a given drug
or set of drugs rests. According to Lloyd D Johnston [54], these include; awareness to the
drug by potential users, access to the drugs, motivation to use the drugs, reassurance and
willingness to violate social norms. All these factors are important not only for the popu-
larity of the drug but also the expansion of the epidemic. When the population becomes
aware of existence of the drug and its psychoactive potential, they can entertain the idea
of using it. For most of the communicable diseases some individuals become aware of the
risk of becoming infected and may choose either to take action or not [47]. This similar
attitude is exhibited by drug users. By awareness to drugs, we refer to the population
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having vivid knowledge about the merits and demerits of using a particular psychoactive
substance. This may not be the case as some people use the drugs thinking that they will
get better and end up getting addicted. The media undoubtedly plays a significant role
in spreading the awareness of a particular drug throughout the population [54], and the
same way reducing the prevalence of an epidemic [20], by encouraging behavioural change.
Important evident case of awareness to substances can be confirmed from the many radio
and television advertisements of cigarettes, and alcoholic products/brands such as Castle
lager, Black label, Strong bow, Heinken, Bell, Carlsberg, Namaqua among others. Often
times such advertisements completely outnumber the educational and sensitization pro-
grams. There is also a wide distribution of shebeens, wine testing places, and liquor shops
most especially in Stellenbosch/western Cape. All these contribute to the population’s
access to the products as well as increasing awareness to the advertised products.
(a) (b)
Figure 1.2. Some selected brands of alcoholic products and wines commonly advertised
We note that, drug using career spreads faster when there is access to drugs and poten-
tial users are motivated by the psychoactive reassurances of the drug. It is believed that
awareness without access can not result into use although increased access can result in
awareness. For psychotherapeutic substances, there is easy accessibility due to their being
widespread due to commercial distribution. In the same line, when the demand for psy-
chotherapeutic drugs surpasses the amount that can be supplied from legitimate routes,
then illegal importation or manufacture from clandestine laboratories may evolve to meet
the demands. The main motivation for consuming drugs by the young stars has a lot
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to do with psychological copying and conformity to the “group” most especially if social
networking entails membership and conformity to a particular clique. Social modelling is
cited as one of the most powerful mechanisms through which interest and motivation to
use drugs is aroused. The strongest association found is a smoking area where a child
raised by smoking parents and whose older siblings smoke becomes a smoker. Therefore,
the modelling comes not only from friends but also others in one’s most immediate role
set, media and complete strangers. When the potential users observe the benefit of using
a particular drug outweighing the cost of using the drug and the adverse effect, then re-
assurance has been obtained. It can also be obtained through a variety of ways including
assertion by others in one’s immediate environment.
Substance abuse is associated with many dangers including the less well known such as
holoprosencephaly (HPE) in fatal alcohol syndrome and leukoencephalopathy which is
associated with inhaled heroin [9]. In this thesis, we detail some of the effects of drugs
on the brain, some effects on the neuronal pathways and the resulting damage that can
lead to disruption of cognitive and motor functions. The challenges are briefly organised
in accordance with specific drugs and we concentrate more on the highly prevalent drugs
including injectable drugs. The drugs have different modes of administration which include
smoking, snorting (snuffing), oral ingestion and others are intravenously administered.
The mode of administration determines the rate at which optimal levels of the drug in
blood are reached [45] and the many harms including Chronic Obstructive Pulmonary
Disease (COPD), Pulmonary edema, pulmonary hypertension, associated with abusing
drugs [9, 40, 45]. The doctrine of types and nature of drug use involves recreational
settings, society, family life experiences and psychiatric disorders.
1.1.1 Alcohol
Intoxication with alcohol to levels of over 0.1 percent/ml of blood has a significant fatality
rate. Such a concentration impairs psycho-motor skills, causing errors in judgement, dis-
orientation and hyperthermia [9]. As a result many accidents arise due impaired divided
attention most especially in activities which require concentration such as driving and
cycling, water sports and swimming, diving and boating accidents due aggravated spinal
cord injuries and failure of the intoxicated individual to hold his breath. It is also impor-
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tant to note the exasperating effects of intoxication on the central nervous system such
as cerebral edema as a result of lipid peroxidation [21], association with low bone density
(osteopenia) and skeletal disorder. Alcoholics often have deficiencies in minerals such as
calcium, phosphate and magnesium [8, 44, 51, 89], as well as vitamin D which is vital for
absorption of calcium from the intestinal system. Alcohol abuse has long been associated
with impotence, sterility, testicular atrophy [99] and low testosterone [90] in men and early
onset of menopause, miscarriage, impaired fertility and low birth weights among others in
women. Excessive consumption of alcohol affects induction of polyamines [48] which regu-
late deoxyribonucleic acid (DNA) synthesis which reduces cell protein and DNA synthesis
in normal osteoblasts [18, 28]. Alcohol has also been associated with cancers, gastric and
ulcer disease, increased risk for colon cancer [32, 33], pancreatitis and liver cirrhosis which
is the most serious damage to the liver. This impairs functioning of the liver leading to
primary hepatic encephalopathy, a brain disorder characterised by altered psycho-motor,
intellectual and behavioural functioning [9]. Chronic alcohol levels deplete hepatic levels
of vitamins A and E antioxidants.
Cardiovascular disease has claimed lives of many people worldwide and the total alcohol
consumed in a life span is directly associated with heart damage. The major condition is
known as alcoholic cardiomyopathy characterised by deterioration of muscles of the heart.
This is the major cause of heart failure and death [67, 68]. Other cases include hypertension
associated with the action of alcohol on the Automatic Nervous System (ANS). This leads
to release of stress hormones adrenaline and norepinephrine which constrict the blood
vessels increasing blood pressure [9], increased ischemic and hemorrhagic strokes.
Although the relationship between alcohol consumption and subsequent sexual behaviour is
not well understood, it is strong. For men arousal can be enhanced by mere expectancy that
drinking has occurred. Alcohol is believed to provoke and heighten sexual responsiveness
[3, 12]. However, the link between alcohol and sexual stimuli is complex since it involves
psychological and physiological processes. The intensity is inversely proportional to the
increase in blood alcohol concentration (BAC) in a linear fashion [10, 25]. In women
increase in BAC is associated with reduced sexual arousal [107] and increases the time
required to attain orgasm [60]. This can encourage multiple sexual relations especially if
one partner is sexually inept.
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1.1.2 Cocaine
Cocaine is an alkaloid occurring naturally and can be obtained from the plant “Erythroxy-
lon Coca L". It can also be chemically synthesised with cold aqueous succinaldehyde, and
cold aqueous methylamine, hydrogen chloride and the potassium salt of acetone-carboxylic
acid monomethylester [45]. It is used medically by otorhinolaryngologists and plastic sur-
geons as an epinephrine cocaine mixture. The different modes of administration of the
drug determine the rate at which cocaine appears in blood stream. These modes of ad-
ministration detailed here and the corresponding times at which optimal levels are reached
are based on [45] as follows; (1) Chewing powdered coca leaves containing 17-48 mg of
cocaine produces a peak plasma concentration of 11-149 ng/ml at 0.4-2 hours of adminis-
tration. (2) Orally taken gelatin capsules (2 mg/kg), the plasma concentration can reach
the peak of 104-424 ng’ml in 50–90 minutes. (3) Through intranasal route, plasma con-
centrations of cocaine are reached between 35-90 minutes after “snorting". (4) Intravenous
administration results in the plasma peak concentration in about 5 minutes. (5) It can be
administered through smoking. In the study that was conducted [45], 50 mg of cocaine
were smoked and the peak plasma concentration of 203 ng/ml was reached in 5 minutes.
Pharmacologically cocaine is associated with effects such as tachycardia, vasoconstriction,
mydriasis and hyperthermia. As a result of central nervous system (CNS) stimulations,
there is increased alertness, diminished appetite and increased energy. Cocaine also acts
as a local anaesthetic because of its ability to block the sodium channels in neuronal cells.
1.1.3 Marijuana
Marijuana refers to the plant cannabis sativa in all its forms (seeds, resin extracts from
the plant, salt, derivative or mixture) except the mature stalk [45]. A variety of names are
being used to refer to the drug such as weed, dope, pot, mull and leaf. It is commercially
cultivated for hemp production. The bulk of the commercially cultivated plant consists of
stalks with very little foliage, except at the apex. In contrast, the wild plants and those
cultivated illegally posses numerous branches and a variety of psychoactive ingredients
are concentrated in the leaves and the flowering tops. By 1995, the number of natural
compounds identified in cannabis sativa was 483, and recently 6 new compounds new
flavanoids have been discovered [46]. Marijuana is an annual plant and is cultivated in most
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parts of the world such as the Canadian-American border, primarily by Asian gangs [46],
in South Africa [73], Australia among other countries. The major psychotic constituent
of marijuana is delta-9-tetrahydocannabinol (THC). Its concentration in the plant varies
from part to part. Marijuana is administered as follows [45]; (1) The major route is by
self administration through smoking leaves rolled in form of a cigarette. However, up to
30% loss of THC is established due to pyrolysis and side stream smoke. Peak plasma
THC concentration occur after 3-8 minutes and THC is present in the blood after the first
puff from marijuana cigarette. When the drug is into the lungs (alveoli), there is rapid
absorption into the blood stream and then transported to the brain. (2) When orally
ingested, THC is 90 to 95% absorbed even though the oral route results in lower peak
plasma concentrations of THC occurring at a later time. (3) Intravenous administration of
4 to 5 mg results into peak plasma concentrations of THC occurring in about 30 minutes.
Marijuana may produce a variety of effects such as sedation, euphoria, hallucinations,
temporal distortion and delusion among others [45]. THC exerts effects on prostaglandin
synthesis, DNA, RNA and protein metabolism. There are two cannabinoid receptors-CB1
and CB2 which are primary targets of endogenous cannabinoids (endocannabinoids). CB1
receptor is found in the brain while CB2 receptor is found in the immune tissues e.g spleen,
thymus and tonsils. Therefore, marijuana not only works as a psychoactive substance but
also affects the immune response.
1.1.4 Heroin and Whoonga
Heroin is a well known addictive substance. Information about the modes of administra-
tion and the related psychoactive and behavioural effects have been detailed in [45, 93].In
the case of South Africa, heroin has not gained much popularity because of the stigma
against injecting drugs. Therefore, in the areas where it is prevalent, it is mainly smoked.
The drug using population has been rocked by a new mainly smoked highly addictive
drug (Whoonga), a derivative of heroin, that has come up in the townships surrounding
Durban-South Africa. Whoonga is a mixture of various substance which include heroin,
HIV medication (Anti-retrovirals), rat poison and detergents among others [86, 93]. The
users become anxious and aggressive in addition to suffering from various pains including
back pain, excessive sweating, headache, and potentially deadly stomach cramps. Such
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symptoms are believed to be cured by a single dose, every time they arise. This leads to
addiction and users resort to committing crimes to feed their addiction.
1.1.5 Substance Abuse and the Immune System
Drugs such as cocaine, marijuana, methamphetamine, heroin and nicotine are known to
weaken and suppress immune function [104]. The suppression of immune function is due
to immunomodulation and this increases susceptibility to infections and has a direct ef-
fect on pathogenesis of infectious diseases. Immunomodulation may be directly due to
the toxic agents contained in the substances or indirectly due to the effects on the neu-
roendocrine system [29]. Illicit drugs especially the injection drugs are associated with
increased transmission of HIV, hepatitis B and C together with other infectious diseases
[22, 50, 88] through the central nervous system and brain function [30, 104]. According to
[29, 34], opiates such as morphine and heroin have been associated with a decrease in the
T-helper/cytotoxic T-cell (CD4/CD8) ratio in addicts.
1.2 Drug Abuse Versus Behaviour
Drugs affect important parts of the brain, necessary to control life-sustaining functions
and can influence compulsive drug abuse that marks addiction. The main parts affected
by addiction to drugs include [87]:
1. The brain stem; which controls basic life critical functions such as heart rate, breath-
ing and sleeping.
2. The limbic system which links the brain structures necessary to control and regulate
pleasurable feelings. Pleasure motivates us to repeat behaviours that may be crit-
ical to our existence. The limbic system is activated when we perform the critical
activities and also by drugs of abuse.
3. The cerebral cortex; the frontal cortex is the center for thinking in the brain which
powers our ability to think rationally, solve problems, plan and make decisions. If the
frontal cortex is affected by stimulation due to drugs, rational thinking is impaired.
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Substances like marijuana and heroin can activate neurons since their chemical structure
mimics that of neurotransmitters although not exactly in the same way as the neurotrans-
mitters. Amphetamine and cocaine can disrupt communication channels [101] through am-
plification of the messages sent to the brain. Direct or indirect stimulation with dopamine
produces euphoric effects which teach people to repeat life sustaining behaviour sought by
drug abusers without thinking about the outcomes. Drug abuse erodes a person’s ability
to make rational decisions and one’s self control while amplifying the desire to take drugs.
Information about addiction to crank cocaine indicates that addiction can further increase
users’ exposure to unprotected sex as a means to obtain drugs. It is rational to believe
that such behaviour can cut across most of the psychoactive substances. Therefore, phys-
iological consequences of addiction may alter susceptibility to infection and interact with
HIV treatment drugs.
1.2.1 Substance Abuse and HIV/AIDS
At the end of 2008, an estimated 33.4 million people in the world [31.1 million-35.8 million]
were living with HIV/AIDS. There was an estimated 2.0 million [1.7 million-2.4 million]
deaths due to the killer epidemic. sub-Saharan Africa remains the most heavily affected
with an estimated 22.4 million people living with HIV/AIDS and the same region accounted
for 71% of all recorded new infections in 2008 [95]. Most countries have reported HIV
infection in most of their administrative regions with an estimated 6.85 million people
living with HIV/AIDS in South Africa [95]. The major modes of transmission include
sexual contacts among homosexual and bisexual men, in the heterosexual population with
an infected person and mother to child transmission. The virus can be introduced into
the blood stream through contaminated needles of transfusion of contaminated blood as
well as perinatal transmission. According to [11], the AIDS incidence in the United States
is highest among homosexual or bisexual men and intravenous drug users. Although the
HIV virus is spread mainly through sexual contact with infected people, it became clear
early in the epidemic that the virus was being spread through other means such as sharing
injection equipment mainly by injecting drug users. It has been observed that, the future
course of HIV pandemic in the most populous countries will be determined by emerging
epidemics [94]. In this report a detailed description of HIV prevalence among IDUs and
sex workers (with a big problem in brothels) in some selected sites in Indonesia is given,
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with a close link between HIV prevalence and injectable drug use. In these most populous
countries, HIV transmission has been on an increase recently . An estimate of 15.9 million
people were IDUs of whom 3 million may be living with HIV [98]. According to [69], drug
addiction plays a significant but less recognised role in the transmission of HIV. Intoxication
by drugs alters the users’ mental status and judgement, which increases the probability of
engaging in high risk behaviour which include.
• Unprotected sexual contact among the intoxicated drug users and, or sexual partners.
This includes improper usage of condoms when intoxicated.
• Engaging in commercial sex work.
• Acquisition of multiple sexual partners and intensification the drug users’ sexual
desire catalysed by stimulants and psychoactive substances.
Drug use and has not only been problematic in the Western world, but also on the African
continent. In Table 1.1, we give figures of some selected countries showing the association
between Drug use and HIV/AIDS prevalence.
Table 1.1. Source [49]: Drug-related HIV risk behaviour and HIV prevalence per country
The faster growth in the incidence of HIV in many regions has been attributed to emerging
epidemics among injecting drug users (IDUs) in Russia, India and China [35]. In China
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IDUs account for 60–70% of all reported infections, although the importance of heterosexual
transmission has increased to 7% [35]. In India, the majority (85%) of new infections are
due to heterosexual transmission, particularly among sex workers (SWs), and the sexual
contacts with their clients. However, in north-east India and major cites such as Delhi,
Chennai and Mumbai, injecting drug use is the major source of new infections [94].
1.3 Perception and Drug Use
When more individuals perceive a drug as detrimental to their health, the consumption
and prevalence tend to reduce. The major example justifying this inverse relationship
between awareness and prevalence is given in the research conducted over a period of 28
years. In this research, the prevalence rate for marijuana use over a twelve months period
and the perception of marijuana as a dangerous drug in 12th graders (18-19 years old) from
1975-2003 in the USA was considered. The data is provided in [43] and the plot of which
is indicated in Figure 1.3, is similar to the one obtained in [102].
Figure 1.3. Shows the observed past year use of marijuana with perceived risk of Marijuana
as a harmful substance.
We observe from Figure 1.3 that, when teenagers perceived marijuana as dangerous, the
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prevalence of drug use was low. This is true for most epidemics in that, people usually
change behaviour on perceiving the risk of infection.
1.4 Project Motivation and Objectives of the Study
1.4.1 Motivation
Substance abuse epidemics have very complex dynamics ranging from the change in the
number of drug users, the type of drugs an individual consumes as their primary or sec-
ondary drugs, and the amount of a particular drug an individual may need to quench the
addiction. Substance abuse imposes heavy budgetary constraints in many countries. For
example it costs South Africa over R20 billion annually [93], in the course of treating drug
users, cracking down drug traffickers and in prevention and media campaigns. According
to the United Nations Office on Drugs and Crime (UNODC), an estimated 155-250 million
people in the world (3.5 to 5.7% of the population aged between 15 and 64) used illicit
drugs at-least once in 2008. Cannabis users comprise the largest number (129-190 million
people) [98]. There is a likelihood that the number of drug users is under estimated since
some people start abusing drugs at a much lower age. Here we cite an example of South
Africa where Gautenge’s youngest known drug dealer was the eight year old boy from Dou-
glasdale [93]. The primary drugs of abuse among people who reported to treatment centres
in Africa, Americas, Europe, Asia, Oceania are listed in [98] and these are associated with
morbidity. The top abused illicit drugs are: Cannabis, in Africa and Oceania with an aver-
age (un weighted) consumption of 63.4% and 46.5% respectively, the sum of all cocaine in
Americas 46.4%, opiates in Asia and Europe at 61.8% and 48.3% respectively [98]. On the
other hand, it is claimed that cocaine and heroin are at the fore front among the abused
illicit drugs in sub-Saharan Africa [42]. Since drug use is illegal, accurately predicting the
population of drug users, estimating the associated budgetary constraints,and analysing
the cost effectiveness of the control measures remain daunting task.
Mathematical models have become handy in predicting the drug use patterns, estimating
the prevalence and consequently the population of drug users, and lastly analysing the
factors that influence drug use patterns and predicting possible remedies to the epidemic.
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1.4.2 Project Objectives
The main objective of this work is study the dynamics of substance abuse. In particular,
to construct a useful mathematical model incorporating important macro-epidemiological
parameters influencing the spread of the epidemic and possible control strategies. The
objectives of the study are;
1. To give a general understanding of substance abuse, modes of administration of
drugs, factors influencing the spread of the epidemic and the morbidity associated
with substance abuse.
2. To study the variation of the population of substance users and the impact of vi-
tal parameters such as rehabilitation, amelioration and re-initiation/relapse on the
prevalence of substance abuse.
3. To investigate through scenario analysis and simulation procedures, the influence of
drug lords interacting with the susceptible population, law enforcement targeting
drug lords, on the prevalence of substance abuse.
4. To investigate the potential impact of substance abuse on the prevalence of HIV/AIDS.
1.5 Mathematical Preliminaries
1.5.1 Definitions and Notations and Propositions
For the definitions, propositions and lemmas given in this subsection, we closely follow
work in [53, 76]. Let U be an open set of Rn. A function f : U → Rn is said to be a Cr
map for 0 ≤ r ≤ ∞ if all partial derivatives up through order r exist for all points of U
and are continuous. In the extreme case C0 means that f is continuous and C∞ means
that all partial derivatives of all order exist and are continuous on U .
Definition 1.5.1. [53] A function f : U → Rn is a Cr map if fi := πif is C
r for
i = 1, 2, . . . n where πi : R
n → R is the ith projection map defined by πi(xi, . . . , xn) = xi.
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Let xi 7−→ f(xi) be a map from an open subset D1 ⊂ Rn to Rn such that each solution
x(t) to the system of differential equations
x˙i = f(xi) (1.1)
is uniquely determined by its initial conditions xi(0) = xi0, and denote the solution by
x(t, x0). Let the nonlinear system (1.1) have a linear form given by
x˙i = Ax, (1.2)
with A = Df(x0).
Proposition 1.5.1. Let U be a non-empty open subset of Rn and let f : U → Rn be a C1
map. Then f is differentiable at all x ∈ U and
Df = Jf :=


∂f1
∂x1
∂f1
∂x2
· · · ∂f1
∂xn
∂f2
∂x1
∂f2
∂x2
· · · ∂f2
∂xn
...
...
. . .
...
∂fn
∂x1
∂fn
∂x2
· · · ∂fn
∂xn

 .
Clearly, Df(x) = Jf(x) : Rn → Rn, where the entries of the Jacobian matrix are evaluated
at x = (xi, . . . , xn). Let also x
∗ ∈ E be an equilibrium point of (1.1).
Definition 1.5.2. A point x∗ ⊂ Rn is an equilibrium point of (1.1) if f(x∗) = 0. x∗ is
called a hyperbolic equilibrium point of (1.1) if non of the eigenvalues of the matrix Df(x∗)
has a zero real part.
Definition 1.5.3. x∗ is said to be locally stable or simply stable if, for each neighbourhood
U of x∗, there exists a neighbourhood V of x∗ such that x(t, v) ⊂ U for all v ∈ V and for
all t > 0.
In other words, if x∗ is a stable equilibrium point of (1.1), no eigenvalue of Df(x∗) has a
positive real part. In this case the solutions starting at nearby initial conditions, remain
close to x∗. More precisely, x∗ is stable if and only if for any ε > 0, there exists a
corresponding number δ(ε) > 0 such that
‖x(t0)− x
∗‖ < δ(ε) =⇒ ‖x(t)− x∗‖ < ε
for all t > t0.
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In this case, x∗ is said to attract points in a neighbourhood W if x(t, x0) → x∗ as t→∞
for each x0 ∈ W . We also note that x∗ may fail to be stable when it attracts points in the
neighbourhood of W .
Definition 1.5.4. If x∗ is stable and attracts points in a bound set W , then the attraction
is uniform with respect to x0 ∈ W and x is asymptotically stable.
An equilibrium point x∗ is asymptotically stable if there exists δ > 0 such that
‖x(t0)− x
∗‖ < δ =⇒ lim
t→∞
‖x(t)− x∗‖ = 0.
That is, all solutions starting sufficiently close to x∗ will converge to x∗. This can be
summarized into the following lemma.
Lemma 1.5.1. Let D1 be an invariant space containing an open set E. x
∗ ∈ E is asymp-
totically stable if it is stable and attracts the neighbourhood (all points in the basin of
attraction) of E ∈ D1.
Definition 1.5.5. An equilibrium x∗ is said to be globally asymptotically stable with respect
to an open set E if it is asymptotically stable and its basin of attraction contains D1
The local stability of systems of differential equations describing the flow of epidemics is
done using the linearisation method. this is motivated by Theorem 1.5.1
Theorem 1.5.1. (Hartman-Grobman Theorem)[76]. let E be an open subset of Rn con-
taining the origin, let f ∈ C1(E), and φt be the flow of the non-linear system (1.1). Suppose
that f(0) = 0 and that the matrix A = D(f(0)) has no eigenvalue with zero real part, Then
there exists a homeomorphism H of an open set U containing the origin onto an open
set V containing the origin such that for each x∗ ∈ U , there is an open interval I0 ⊂ R
containing zero such that for all x∗ ∈ U and t ∈ I0
H ◦ φt(x
∗) = eAtH(x∗) (1.3)
that is H maps trajectories of (1.1) near the origin onto trajectories of (1.2) near the origin
and preserves the parametrisation by time.
Thus the two autonomous systems are said to be topologically equivalent. For the outline
of the proof of Theorem 1.5.1, see [76]. We use the linearisation method to prove local
stability of the system. On the other, hand if the equilibrium point of Df(x∗) is non-
hyperbolic, then the linearisation process does not provide enough information about the
stability of the equilibrium point. We then use the lyapunov function as described below.
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Let the function V be a continuous function defined as V : Rn → R. If V satisfies the
hypotheses in Theorem 1.5.2, then it is a Lyapunov function
Theorem 1.5.2. Let E be an open subset of Rn containing x∗. Suppose that f ∈ C1(E)
and that f(x∗) = 0. Suppose further that there exists a real valued function V ∈ C1(E)
satisfying V (x∗) = 0 and V (x) > 0 if x 6= x∗. Then
(a) if V˙ (x) ≤ 0 for all x ∈ E, x∗ is stable;
(b) if V˙ (x) < 0 for all x ∈ E \ {x∗}, x∗ is asymptotically stable;
(c) if V˙ (x) > 0 for some x ∈ E \ {x∗}, x∗ is unstable.
A lyapunov function is challenging to construct, but once one is constructed and satisfies
the first two conditions of Theorem 1.5.2, then the associated steady state of the dynamical
system is stable. In addition, lyapunov like functions have been used to prove persistence
and permanence of the population in both epidemiological and ecological models. An
example of this application to prove persistence of solution is illustrated with the model in
section 3.5.
1.6 Outline of the Thesis
In Chapter 1 a general background of substance abuse is provided, citing the factors influ-
encing the spread of the epidemic, major substances abused, modes of administration and
the related times at which peak plasma concentrations are reached. It is in this chapter
where we gave the close association between substance abuse and behaviour and conse-
quently the spread of HIV/AIDS. We also indicated a number of medical complications
which arise from using substances, the associated immune suppression, and alteration of
functioning of natural killer cells. In this chapter we showed basing on the available re-
search results that increased awareness of the risk of using substances results in decreased
prevalence of such drug epidemics. Lastly, we gave some mathematical preliminary defi-
nitions and concepts needed in the later chapters. In Chapter 2, we review some studies
done on modelling substance abuse and compartmentalisation of the “core” population. In
Chapter 3, we formulate a deterministic drug using compartmental model incorporating
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rehabilitation/treatment, amelioration and re-initiation into substance abuse as the socio-
logical parameters and then analyse how each of these parameters influences the prevalence
of substance abuse. In Chapter 4, we extend the model to incorporate the influence of drug
lords as the leaders of the black market, and how law enforcement may impact the preva-
lence and incidence of substance abuse. In Chapter 5, we analyse the potential impact of
drug abuse on the prevalence of HIV/AIDS and lastly, in Chapter 6, we present the general
discussion and conclusion to the thesis and give commendations of possible improvement
of the model to better understand drug epidemics and further research.
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Literature Review
2.1 Substance Abuse Models
The general ideas and techniques used in mathematical modelling of epidemics and infec-
tious diseases begin with the disease statistics dating from Daniel Bernoulli’s smallpox data
of 1760. This resulted in description of simple deterministic and stochastic models in con-
tinuous and discrete time for epidemics occurring in homogeneous and non homogeneous
populations. Both types of models (stochastic and deterministic) have a role to play in
describing the spread of infections in small and large populations respectively. Interesting
to note is that, a wide range of techniques for constructing and analysing epidemic models
in human populations are now available, but mostly in the context of viral and bacterial
diseases. The main interest of the modelling process is to fit realistic mathematical models
to data, and use the models and data to; estimate the vital parameters driving the epi-
demic, devise necessary strategies for controlling the spread of epidemic and then advise
policy makers and health practitioners on how to abate the epidemic burden.
Compartmental models have been used to analyse the dynamics of epidemics in the popula-
tion, as well as describing and understanding the various aspects of substance abuse which
include “measuring” of substance abuse prevalence and the response to drug use control
interventions [80, 81]. In these compartmental models, the population is categorised into
different sub-populations where members in the compartment are at the same level of in-
fection (homogeneous) and the different compartments are heterogeneous. The general
19
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population is classified into two categories; “movers” and “stayers” [80, 81] or “core” and
“non core” group [71]. The movers/core group, form the major susceptible pool for drug
epidemics. They can be initiated into drug use and they continue with the drug using ca-
reer. The stayers/non-core group, is a group of individuals who are not prone to initiation
into drug use due to their “circumspect” behaviour.
There has been growing interest in mathematical modelling of substance abuse dynamics.
The reasons for this are; to understand the dynamics and evolution of the population
of substance abusers, initiation into drug use, prevention and treatment strategies. The
modelling approach is based on the evidence that drug use spreads as an infectious disease
with the rate of occurrence of new cases depending on the number of drug users and the
susceptible population [57, 81]. The main difference between drug users and the “infected”
persons is a microbial process [57]. However, drug use being illegal, estimating the actual
population of drug users is challenging as opposed to infectious diseases. In addition, the
sociological parameters in the drug field may be area/country specific and may not be
presumably the same in different countries as the case may be for infectious diseases [81].
In [5], analysis of drug use with optimal control of drug epidemics involving prevention
and treatment was based on a first order ordinary difference equation model introduced by
Everingham and Rydell [24] and described by Behrens et al. in [23]. In the model, initiation
into drug use was made an endogenous function of prevalence as in [6], and involved a group
of self initiated drug users referred to as “innovators”. Since drug users do not behave as
diseased individuals, distinguishing between light users and heavy users may be challenging.
Everingham and Rydell (1994) [24], with their simple two-state Markov model of cocaine
demand distinguished between “light users" and “heavy users" as a pioneering contribution
of understanding drug policy. They classified individuals who reported using cocaine “at
least weekly” as “heavy users” and those who consumed within the past year but less than
weekly as “light users".
The simplest known epidemic model is the classical SI model, with only two compartments,
the susceptible S and infected population I. Most epidemic models however, are built on
the basis of the classical SIS and SIR models. One of the simplest models of substance
abuse, inspired by the SIR model, was presented by Brandy benedict (2007)[7]. The model
was presented under the acronym SAR, used for modelling alcoholism as a contagious
condition. The model has three compartments: Susceptible (S), Alcoholics (A) and the
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removed or recovered (R). Initiation into substance abuse is proportional to product of the
number of susceptible individuals and the fraction (A/N) of the alcoholics in the population
each susceptible individual encounters. In this model, all the alcoholics were classified to
be in the same group irrespective of their level of alcohol usage. In this model still, no
removal rate associated with alcohol abuse was accounted for. This may be lacking since
heavy alcohol usage is associated with risky behaviour, morbidity and mortality.
Control of drugs has been a global agenda for more than a century now. Efforts have
been directed towards prevention of initiation into drug use and rehabilitation of drug
addicts. The effectiveness and efficiency of control efforts such as education and media
campaigns in preventing initiation into drugs and accelerating quitting can not be easily
quantified. The drug use trends can however be observed through routine data collection
[20]. Mathematical models on substance abuse have been formulated and analyzed by
a number of authors in recent years, see for instance [71, 72, 83, 105]. They have been
insightful in the understanding of the dynamics of substance abuse, initiation into drug
use, prevention and treatment strategies. The fact that drug users do not behave like
diseased individuals, estimating the actual population of drug users may be challenging.
Therefore, knowledge of the epidemiology of drug use patterns, social networks and the
potential impact of drug epidemics is essential.
Two models on drug epidemics have been proposed recently. The first model was by White
and Comiskey [105] on heroin epidemics. In their model, three classes of individuals were
considered, namely, susceptibles, heroin users not on treatment and heroin users on treat-
ment. A drug epidemic threshold, the basic reproduction ratio, was determined and the
model analysis was based on the threshold parameter. Stabilities of the equilibria of the
model in [105] were proved by Mulone and Straughan [64] under a realistic condition that
the relapse rate of those in treatment returning to untreated drug use is greater than the
prevalence rate of susceptibles becoming drug users. The model was extend in [71] to model
methamphetamine abuse in Western Cape. In the extended model Figure 2.1(b), the class
of drug users not on treatment was divided into classes of drug users who are allowed to
pass through a period of concealed drug use at the beginning (light drug users) and hard
drug users. The model allowed for quitting/recovery of those under treatment into a class
of the recovered and a relapse for the recovered individuals. The model in [105], was also
modified by Samanta [83], through the introduction of time dependent parameters, time
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dependent total population size and distributed time delay.
A typical drug use cycle consists of being at risk, concealed drugs use soon after initiation,
addiction, treatment, recovery and relapse, whose dynamics are not well understood. Un-
like in [71, 83, 105], in addition to treatment- recovery-relapse cycle, we also assume an
ameliorative process that considers the transfer of hard drug users, to light drug use and
to being at risk again but not using drugs. The model assumes two processes of quitting
drugs; firstly through rehabilitation and secondly through a systematic withdrawal process
in which an individual moves from being a hard drug user, to a light user and to complete
recovery. In [71, 83, 84, 105], the models assume that once an individual starts using drugs,
they can not be susceptible or be at risk again. See the sample flow diagrams indicated in
Figure 2.1. This assumption may not be realistic in our view.
(a) Source [84]: A flow chart of a smoking a epidemic
model.
(b) Source [71]: A compartmental representation of
the epidemic of methamphetamine use
Figure 2.1. Sample flow diagrams used in modelling substance abuse.
In the first phase of drug use, users can either stop using drugs, continue using drugs or
die [81]. When they stop using drugs, they become susceptible again and if they continue
using drugs they become addicts. We allow drug addicts to either revert to light drug use
or to be recruited into rehabilitation programs.
In this thesis, we thus propose a mathematical model for a drug epidemic in which amelio-
ration, treatment and relapse are considered with the aim of studying the global dynamics
of the model. Sufficient conditions ensuring the existence and uniqueness of globally stable
equilibria are derived using the direct Lyapunov method. Determining the global stability
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of equilibria in models with several classes is not trivial. We analyse the global stability of
the model formulated and give some numerical simulations. We then extend the model to
incorporate the influence from drug lords in the initiation process and the impact of law
enforcement on the prevalence of substance abuse. Finally, we use the first model, and
involve the transition of drug users to HIV/AIDS seropositive state based on non-linear
transmission due to their involvement in risky behaviour, and then analyse the impact of
substance abuse on the prevalence of HIV/AIDS.
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Model with Amelioration
3.1 Introduction
Mathematical modelling in population biology, ecology and epidemiology has been develop-
ing for many years to monitor the evolution of human populations over time, water-borne
and zoonotic infections, micro and macro-organism, chemostat and enzymatic reactions,
cellular and metabolic pathways, tropical and many infectious disease among others. Be-
havioural driven epidemics such as substance abuse have been a menace to communities
accounting for significant morbidity and mortality, but little research has been done to
understand such epidemics. Drug epidemics drive many other epidemics especially, those
involving heightened sexual arousal arising from consumption of psychoactive substances.
In this chapter, we formulate a deterministic model for substance abuse dynamics inspired
by the work done in [71, 84]. The purpose of our modelling work is to identify and quantify
the contribution of some key parameters driving the epidemic. The following differentiate
our model from the models presented in [71] and [84] as follows:
(i) We allow for amelioration of heavy drug users to the light drug using class and
reversion/relapse of drug users under rehabilitation into heavy drug use, since re-
habilitation may not be 100% effective and also due to withdrawal effects. Direct
reversion for the rehabilitation class to heavy using class is because, the amount sub-
stance needed by relapsing individuals to feel “normal” is almost equal to their usage
level.
24
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(ii) We also consider quitting for light users since after initiation some individuals may
not like the drug or change behaviour and quit. In the same way, heavy drug users on
the road to recovery (ameliorating drug users), may quit slowly through light drug
use but remain at risk of using drugs.
(iii) Unlike in [84], we include a drug related removal rate for heavy drug users used in [71].
We also account for an additional removal rate for drug users under rehabilitation.
3.2 Mathematical Model Formulation
The model analyses the dynamics of drug abuse in a heterogeneous population. The
population is stratified into four classes: those at risk of using drugs (susceptible) denoted
by S, light users L, heavy users H , and drug users on treatment T . The total variable
population size at any time t is given by
N(t) = S(t) + L(t) +H(t) + T (t).
We assume that the individuals in each compartment are indistinguishable and there is
homogeneous mixing. The model assumes that individuals join the susceptible population
at a rate π through births and immigration. Susceptible individuals are initiated into
drug use following interaction with individuals using drugs. We thus assume an initiation
function that is analogous to the force of infection for epidemic models. In this case, the per
capita contact rate β is a product of the effective number of contacts c, between drug users
and the susceptible population, and the probability βˆ, that a contact results in initiation
into drug use so that β = cβˆ. A fraction Lf(N) of the contacts are with light users and the
average number of relevant contacts of each individual with light users is βLf(N), where
f(N) is the density function. Also, η1βHf(N) and η2βTf(N) are the relevant contacts of
each individual with a heavy user and a user under treatment respectively. The parameters
η1 and η2 measure the relative ability to initiate new drug users for heavy users and those
in treatment respectively when compared to light users. Assuming that the rate at which
heavy users and those in treatment recruit initiates is lower than that of light users, we
have 0 ≤ η1, η2 < 1. This is due to the fact that problematic drug use is associated with
morbidity and this serves as “negative” advertisement. The total number relevant contacts
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gives the initiation function using mass action incidence,
Λ = f(N)β (L+ η1H + η2T ) . (3.1)
Upon infection, a susceptible individual moves into the compartment of light users. The
light use phase, represents initial phase of drug abuse and individuals can either stop, die or
move to heavy drug use. It is at this stage that our model differs from a number of models
on substance abuse. We argue that this approach is representative of drug use cycles.
Heavy drug users can either revert to light drug use, die, join rehabilitation programmes
or they are removed due to drug use related problems. Removal due to substance abuse
related problems include incarceration and deaths directly caused by the use of drugs.
This is of particular importance when one considers the fact that drug abuse often impairs
judgement for drivers, increases the risk of contracting killer diseases such as HIV and
often leads to violent crimes as addicts search for money to buy drug doses. Once in
rehabilitation individuals can either have a relapse to hard drug use, quit permanently, die
or they are also removed due to drug use related problems. The possible transitions of a
drug user’s career are represented by the schematic diagram, Figure 3.1.
Figure 3.1. Model diagram indicating possible transitions in the drug using career
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The model system of ordinary differential equations is given below;
dS
dt
= π − ΛS − µS + γ1L,
dL
dt
= ΛS + γ2H − (µ+ σ + γ1)L,
dH
dt
= σL+ γ3T − (ρ+ γ2 + µ+ δ1)H,
dT
dt
= ρH − (γ3 + k + µ+ δ2)T.
(3.2)
The descriptions of the parameters that describe the flow rates between compartments are
given in Table. 3.1.
Table 3.1. Description of parameters used in the model.
Symbol Description
β The effective contact rate between drugs users and the susceptible population
η1 The relative ability to initiate new drug users by heavy users
η2 The relative ability to initiate new drug users by users in rehabilitation
π Recruitment rate into the susceptible population
µ Natural mortality rate of the population
σ The mean rate at which light users escalate to heavy drug use
γ1 The rate at which light users quit and become susceptible again
γ2 The rate at which heavy drug users move back into light drug use
ρ The rate at which heavy drug users are recruited into rehabilitation
γ3 The rate at which those under rehabilitation relapse into heavy drug use
δ1 Removal rate related to drug use for heavy drug users
δ2 Removal rate related to drug use for users under rehabilitation
k The mean rate at which those in rehabilitation quit permanently
3.2.1 The Incidence Function
The incidence function is density dependent. We assume that the density dependence of
the incidence is described by the function f(N). In this case the function class of interest
is f(N) = N−α, where α ∈ {0, 1}. In this set of α, the incidence term includes the two
common forms; mass action or bilinear incidence when (α = 0) and standard incidence for
(α = 1). The incidence term being density dependent, indeed our initiation function is
given by Λ = f(N)β(L+ η1H + η2T ).
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We assume that the function f(N) is continuous and its first derivative is continuous on
R. If f(N) is C1 for N > 0, then f(N) satisfies the satisfies the following assumptions [37];
(P1) f(N) > 0,
(P2) f
′
(N) < 0 and
(P3) |Nf
′
(N)| ≤ f(N) for N > 0 only.
The assumptions that f(N) > 0 and f
′
(N) < 0 are biologically motivated. As the total
population increases, the probability of contact between the drug user and the susceptible
individual decreases. Therefore, the force of infection is a decreasing function of N .
The third condition ensures the uniqueness of the endemic equilibrium when R0 > 1, and
global stability of the drug free steady state when R0 ≤ 1. The conditions imply that
Nf(N) is monotonically non-decreasing since
(Nf(N))
′
= f(N) +Nf
′
(N) ≥ 0.
We now apply the conditions (P1)−(P3) to the class of functions f(N) = N−α , α ∈ {0, 1}.
It can easily be shown that the class of functions f(N) = N−α, satisfies the conditions
(P1) − (P3), only for α = 1. In our model therefore, we use the function f(N) = N−1,
thus the incidence function is based on standard incidence. In this case, we assume that a
susceptible individual meets only a fraction of substance users as opposed to mass action
incidence. The force of infection in this model is thus given by
Λ = β(L+ η1H + η2T )/N.
3.2.2 Basic Properties
Positivity of Solutions
We now consider the positivity of system (3.2). We prove that all the state variables
remain non-negative and the solutions of the system (3.2) with positive initial conditions
will remain positive for all t > 0. We thus state the following lemma.
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Lemma 3.2.1. Given that the initial conditions of system (3.2) are S0 > 0, L0 > 0, H0 >
0 and T0 > 0, the solutions S(t), L(t), H(t), and T (t) are non-negative for all t > 0.
Proof. Assume that
tˆ = sup {t > 0 : S > 0, L > 0, H > 0, T > 0} ∈ [0, t] .
Thus tˆ > 0, and it follows directly from the first equation of the system (3.2) that
dS
dt
= π − (µ+ Λ)S.
We thus have
d
dt
[
S(t) exp
{
µt+
∫ t
0
Λ(s)ds
}]
≥ π exp
[
µt+
∫ t
0
Λ(s)ds
]
.
Hence
S(tˆ) exp
[
µtˆ+
∫ tˆ
0
Λ(s)ds
]
S(tˆ) exp
[
µtˆ+
∫ tˆ
0
Λ(s)ds
]
− S(0) ≥
∫ tˆ
0
π exp
[
µtˆ+
∫ tˆ
0
Λ(w)dw
]
dtˆ,
so that
S(tˆ) ≥ S(0) exp
[
−
(
µtˆ+
∫ tˆ
0
Λ(s)ds
)]
+exp
[
−
(
µtˆ+
∫ tˆ
0
Λ(s)ds
)][∫ tˆ
0
π exp
(
µtˆ+
∫ tˆ
0
Λ(w)dw
)
dtˆ
]
> 0.
From the second equation of (3.2),
L˙ = ΛS + γH − (µ+ σ + γ1)L,
≥ −(µ+ σ + γ1)L,
⇒ L ≥ L0e
−(µ+σ+γ1)t > 0.
Similarly, it can be shown that H(t) > 0 and T (t) > 0 for all t > 0, and this completes the
proof.
Invariant region
Since the model monitors changes in the human population, the variables and the parame-
ters must be positive for all t ≥ 0. The analysis of system (3.2) will therefore be analysed in
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a region Ω1 of biological interest. We have the following lemma on the region that system
(3.2) is restricted to.
Lemma 3.2.2. The feasible region Ω1 defined by
Ω1 =
{
(S(t), L(t), H(t), T (t)) ∈ R4+|S + L+H + T ≤
π
µ
}
is bounded, positively invariant and attracting with respect to system (3.2) for all t > 0.
Proof. The total population in this model is clearly not constant. Therefore, the evolution
equation of the population is given by
dN
dt
= π − µN − δ1H − (k + δ2)T,
≤ π − µN. (3.3)
It can easily be shown that
N ≤
π
µ
+
(
N0 −
π
µ
)
e−µt where N(0) = N0 (3.4)
From (3.4), we observe that as t→∞, N(t)→ π
µ
. So ifN0 ≤
π
µ
then lim
t→∞
N(t) =
π
µ
. Clearly,
π
µ
is the upper bound of N . It therefore follows from this result that (S(t), L(t), H(t), T (t))
of the model (3.2) satisfies
lim sup
t→∞
(S(t), L(t), H(t), T (t)) ≤
π
µ
.
On the other hand, if N0 >
π
µ
, then N will decrease to π
µ
as t → ∞. This means that if
N0 >
π
µ
, then the solution (S(t), L(t), H(t), T (t)) enters Ω1 or approach it asymptotically.
Hence Ω1 is bounded and positively invariant under the flow induced by system (3.2).
Therefore, in Ω1, the model (3.2) is well-posed and it is sufficient to study the dynamics
of the model in Ω1.
3.3 Threshold Number
The central concept in analysing and quantifying the transmission of the infection is the
reproduction ratio R0. As defined by Macdonald [56], the reproduction number is “the
number of secondary infections produced by a single infective individual in an entirely sus-
ceptible population”. We consider our heterogeneous population that can be grouped into
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four homogeneous compartments. We let x = (S, L,H, T )t = (x1, x2, x3, x4)t denote the
individuals in each compartment and (·)t denotes a transpose of a matrix. It is known that
xi ≥ 0 for i = 1, 2, 3, 4. The state space of the model is restricted to the closed positive cone
x ∈ X = R4+. We sort the compartments in such a way that, the last three compartments
are associated with drug use. Then
Xs = {x ≥ 0|xi = 0, i = 2, 3, 4} , (3.5)
is the set of drug free states. Using these definitions, the model system of differential
equations (3.2) given on Xs is given as.
x˙ = f(x) (3.6)
The function (3.6) is comprised of the appearance of new infections (initiations) in a
compartment and transfer rates in and out of the compartment. Note that, if ν+i denotes
the rate of transfer of individuals into a compartment i, ν−i the rate of transfer of individuals
out of compartment i, and F , the rate of appearance of new individuals into compartment
i, then the components of f are fi(x) = Fi(x)−νi(x), where νi(x) = ν
−
i −ν
+
i . According to
our model, each of the functions is at least C1 in each variable and the following conditions
[100] are satisfied.
1. If x ≥ 0, then fi, ν
+
i , ν
−
i ≥ 0 for i = 1,2,3,4
2. If x = 0, then ν−i = 0, thus if x ∈ Xs then ν
+
i = 0 for i = 2,3,4
3. Fi = 0 for i = 1
4. if x ∈ XS, then fi(x) = 0 and ν
+
i (x) = 0 for i = 2, 3, 4
We note that conditions 1. and 2. together with the smoothness assumption on the
functions involved guarantee that, the non negative cone (xi ≥ 0, i = 1, 2, 3, 4) is forward
invariant and for each non-negative initial condition a unique non-negative solution exists.
Condition 3, indicates that the incidence of drug use for non-users is zero and it is satisfied
by the system. This indicates that the eigenvalues of the Jacobian at the DFSS all have
negative real parts, see Subsection 3.3.1. Condition 4, ensures that the drug free subspace
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is invariant and if the population is free of substance abuse, they remain free. This ensures
that there is no immigration of drug users who are not density independent.
We assume that the drug free steady state exists and it is locally asymptotically stable.
By this assumption, if E0 denotes the drug free equilibrium of the system, then F(x) is
set to zeros and all the eigenvalues of Df(x0) have negative real parts.
We obtain the model basic reproduction number using the next generation matrix method
described in [100]. The infective classes involved are L,H, T . We decompose the rates of
change (dL/dt, dH/dt, dT/dt) of the infective classes in terms of two matrices fi and νi
where, fi represents new infections and νi represents transitions. Then we evaluate,
F =
[
∂fi
∂xj
(x0)
]
and V =
[
∂νi
∂xj
(x0)
]
.
x0 is the drug free equilibrium. F is non-negative and V is non-singular. Therefore,
fi =


ΛS
0
0

 and F =


β η1β η2β
0 0 0
0 0 0

 .
In the same way the transition matrix for the model is given by
νi =


−γ2H +Q1L
−σL− γ3T +Q2H
−ρH +Q3T

 and V =


Q1 −γ2 0
−σ Q2 −γ3
0 −ρ Q3

 ,
where
Q1 = (µ+ σ + γ1), Q2 = (µ+ γ2 + δ1 + ρ) and Q3 = (µ+ k + δ2 + γ3).
The basic reproduction number is given as the spectral radius of the next generation matrix
R0 = ρ(FV
−1) = R01 +R02 +R03, (3.7)
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such that
R01 =
(
β
Q1
)(
1− Φ1
1− (Φ1 + Φ2)
)
,
R02 =
(
βη1
Q2
)(
σ
Q1
)(
1
1− (Φ1 + Φ2)
)
,
R03 =
(
βη2
Q3
)(
σ
Q1
)(
ρ
Q2
)(
1
1− (Φ1 + Φ2)
)
,
where
Φ1 =
ργ3
Q2Q3
and Φ2 =
γ2σ
Q2Q1
.
Φ2 is the probability of moving from one of the compartments L and H to the other and
back again. Φ1 is the probability of moving from one of the compartments H and T to the
other and directly back. Each time a light user enters a heavy using class, the expected
number of new initiations is ηβ
Q2
, since 1
Q2
is the average waiting time of heavy users at that
level of infection. The value σ
Q1
is the probability that a light user escalates into heavy
drug use after first being initiated. The term Φ1 + Φ2 represents the probability that a
heavy drug user leaves his class and returns. Using binomial theorem to the first three
terms, the term 1
1−(Φ1+Φ2)
≃ 1 + (Φ1 + Φ2) + (Φ1 + Φ2)
2 + ..., is the expected number of
visits to the H class given that an individual has advanced to H . This result is consistent
with the multi stage infection model [61] with three infectious classes.
3.3.1 Model Analysis
Drug Free Steady State
The drug free steady state is established when L∗ = 0, H∗ = 0, T ∗ = 0. From the first
equation of (3.2), we obtain S∗ = π
µ
. Therefore, the drug free steady state is given by
E0 = (S
∗, L∗, H∗, T ∗) =
(
π
µ
, 0, 0, 0
)
(3.8)
When there is no substance abuse in the population, the susceptible population corresponds
to the total population with a constant steady state N∗ = S∗ = π
µ
. This steady state is
assumed to have a constant inflow from the non core population at a rate π and an outflow
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µ, such that an individual is expected to remain in the S compartment an average of µ−1
years.
Local Stability of the Drug Free Steady State (DFSS)
To determine the local stability of the DFSS, we evaluate the Jacobian of the system (3.2)
at the DFSS. The Jacobian matrix of system (3.2) is given by
J(S, L,H, T ) =


−µ− Λ −βS
N
−βη1S
N
−βη2S
N
Λ βS
N
−Q1
βη1S
N
+ γ2
βη2S
N
0 σ −Q2 γ3
0 0 ρ −Q3

 .
Evaluating the Jacobian at the drug free equilibrium, we obtain
J
(
π
µ
, 0, 0, 0
)
=


−µ −β −βη1 −βη2
0 β −Q1 βη1 + γ2 βη2
0 σ −Q2 γ3
0 0 ρ −Q3

 . (3.9)
We consider stability of the drug free steady state by calculating the eigenvalues of the
Jacobian (3.9). The characteristic equation for the eigenvalues is given by
(λ+ µ)[λ3 + Aλ2 +Bλ+ C] = 0, where (3.10)
A = Q1 +Q2 +Q3 − β = Q2 +Q3 +
Q1
1−Φ1
[R01Φ2 + (1− Φ1)(1− R01)] > 0,
B = Q1Q3
(1−Φ1)
[(1− Φ1)(1−R01) +R01Φ2] +Q1Q2 [(1− Φ2)(1−R02) +R02Φ2]
+
Q2Q3
ση2ρ
[(1− Φ1)(ση2ρ− R03Q1Q2)] ,
C = Q1Q2Q3[1− (Φ1 + Φ2)](1−R0).
Note that if ση2ρ ≥ R03Q1Q2 when R0 < 1, then the coefficient B will be strictly positive.
Otherwise, we can not conclude on the sign of B and it entirely depends on the model
parameters.
It can easily be shown that Q1Q2Q3[1 − (Φ1 + Φ2)] > 0. Note also that, the drug free
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steady state exists when R0 < 1 therefore C > 0. The characteristic equation immediately
gives one eigenvalue λ1 = −µ < 0 and the other eigenvalues are obtained by solving the
characteristic equation
λ3 + Aλ2 +Bλ + C = 0. (3.11)
We analyse the system using Routh-Hurwitz criterion [65], which states that, “ if A >
0, C > 0 and AB − C > 0, then the eigenvalues have negative real parts". Given the
nature of the constants A, B and C, we can not easily decide on the sign of the expression
AB − C. However, using the sum and product of roots of the cubic polynomial equation
(3.11), all eigenvalues have negative real parts if and only if R0 < 1. Therefore, the DFSS
is locally asymptotically stable when R0 < 1 and unstable when R0 > 1.
This result is further supported by the simulation of the characteristic polynomial, equation
(3.11) using parameter values in Table 3.2. The plot of eigenvalues is indicated in Figure
3.2. In the region r1 (R0 < 1), all eigenvalues have negative parts; in regions r2, and r3
(R0 > 1) at least one of the eigenvalues has a positive real.
Figure 3.2. Shows the eigenvalues obtained from the characteristic polynomial
We can summarize the results in the following ways;
1. When R0 < 1, the drug free steady state is locally asymptotically stable if AC−D >
0. The interpretation of this is that the successively “initiated generation” is smaller
than its predecessor, and substance abuse can not persist.
Stellenbosch University http://scholar.sun.ac.za
Chapter 3. 36
2. When R0 > 1, the drug free steady state is unstable. Thus, drug use persists since
the successively “initiated generation” is greater than its predecessors and number
of substance users is expected to initially increase. However, this does not go on
indefinitely. We relate this trend to infectious disease as observed by Heesterbeek
and Roberts [78], that the initiation process reduces the “pool of susceptibles”, which
reduces the probability of drug users contacting with the susceptible population Be-
ginner within their drug using career.
3.4 Global Stability of the Drug Free Steady State
In this section we prove global stability of the drug-free equilibrium E0 when R0 ≤ 1
Theorem 3.4.1. The disease free equilibrium E0 of system (3.2) is globally asymptotically
stable if R0 ≤ 1 and unstable if R0 > 1.
Proof. Let
V (L,H, T ) = aL+ bH + cT
be a candidate lyapunov function for some non negative values of a, b and c. The time
derivative of V is given by
V˙ = aL˙+ bH˙ + cT˙ ,
= a
[
β
(
L+ η1H + η1T
N
)
S + γ2H −Q1L
]
+ b (σL+ γ3T −Q2H) + c (ρH −Q3T ) ,
≤ a [β (L+ η1H + η2T ) + γ2H −Q1L] + b (σL+ γ3T −Q2H) + c (ρH −Q3T ) ,
= [a(β −Q1) + bσ]L+ (a(βη1 + γ2)− bQ2 + cρ)H + (aη2 + bγ3 − cQ3)T.
We now evaluate the coefficients of the suitable Lyapunov function such that the coefficients
of H and T are equal to zero. After algebraic manipulations, we obtain
a = Q2Q3[1− Φ1], b = Q3(βη1 + γ2) + ρβη2, c = βη2Q2 + γ3(βη1 + γ2).
Using these coefficients, the time derivative of the lyapunov function can be expressed as
V˙ = Q2Q3(1− Φ1)L˙+Q3(βη1 + γ2) + ρβη2)H˙ + (βη2Q2 + γ3(βη1 + γ2))T˙ ,
≤ [Q2Q3(1− Φ1)(β −Q1) + σ (Q3(βη1 + γ2) + ρβη2)]L,
= Q1Q2Q3[1− (Φ1 + Φ2)](R0 − 1)L.
For R0 ≤ 1, V˙ ≤ 0; the equality holds only when
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(a) R0 = 1, and L = H = T = 0 or
(b) L = 0.
Let us assume that R0 > 1. Using lemma 5 in [59], we observe that the Jacobian matrix
based on only the infectious classes evaluated at the non trivial steady state (0, 0, 0) has a
determinant given by Q1[1− (Φ1+Φ2)](R0−1). This is positive when R0 > 1 which yields
instability in the system. Therefore, by the LaSalle Theorem [82], the trivial equilibrium
is globally asymptotically stable in the invariant feasible region
Ω1 :=
{
D ∈ R4+|S + L+H + T ≤
π
µ
}
. (3.12)
3.5 Persistence of the Model
Persistence with a continuous flow φt defined on some set E ⊂ Ω1 such that the boundary
of E is invariant under the flow φt, has widespread applications in modelling of dynamical
behaviour of ecological and epidemiological entities [58, 91]. Persistence conveys some
idea that for interacting populations none of the component populations becomes “extinct”
[14, 26]. According to [27], persistence criteria have been analysed using Lyapunov-like
functions and analysing the flow on the boundary of E.
Theorem 3.5.1. The solution to the model system (3.2) is persistent whenever, R0 > 1.
Before proving Theorem 3.5.1, let us give the definition of persistence of the solution of
system (3.2).
Definition 3.5.1. The system of equations (3.2) is said to be uniformly persistent if
there is an η > 0 (independent of the initial data) such that every solution of the model
(S(t), L(t), H(t), T (t)) with some initial conditions (S0, L0, H0, T0) satisfies
lim inf
t→∞
S(t) ≥ η, lim inf
t→∞
L(t) ≥ η,
lim inf
t→∞
H(t) ≥ η, lim inf
t→∞
T (t) ≥ η.
Proof. To show persistence of the solution (proof of Theorem 3.5.1), we capitalize on the
notion of dynamics of a Euclidean space. Let Ω1 be a locally compact metric space with
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metric d and let E1, the endemic state be any subset of Ω1 with boundary ∂E1 and the
interior of E1, E˚1. Suppose we have a continuous flow φ(t) defined on E1, such that ∂E1 is
invariant under φ(t). The flow φ(t) is said to be point dissipative in E1 if for each x ∈ E1,
ω(x) 6= ∅ and the invariant set
Ω(φ(t)) =
⋃
x∈E1
ω(x) has a compact closure.
If we define the ω−limit set of E1 as
ω(E1) =
⋂
T≥0
Cl
⋃
t≥T
φ(t)E1, (3.13)
where
φ(t)E1 =
⋂
x∈E1
{φ(t)x} and Cl is the closure of the set. (3.14)
Equivalently this implies that, y ∈ ω(x) if and only if there is a sequence tn → ∞ as
n→∞ such that φ(t)x→ y as n→∞.
To show persistence of the model population, it is enough to show that for all x ∈ E˚1
lim inf
t→∞
d(φ(t)x, ∂E1) > 0. (3.15)
To show the boundary of E1, we suppose that the drug persistent equilibrium is globally
stable and use a suitable Lyapunov function;
W =
4∑
i=1
Ai
(
xi − x
∗
i − x
∗
i ln
xi
x∗i
)
, (3.16)
where xi for i = 1 . . . 4, represent S, L, H and T respectively. We also note that
∂W
∂xi
= Ai
(
1−
x∗i
xi
)
,
∂2W
∂x2i
> 0. (3.17)
Therefore, E∗1 = (x
∗
1, x
∗
2, x
∗
3, x
∗
4) is the minimum. Suppose that
lim inf
t→∞
S(t) ≥ ηs, lim inf
t→∞
L(t) ≥ ηl,
lim inf
t→∞
H(t) ≥ ηh, lim inf
t→∞
T (t) ≥ ηt.
If we let E∗1 be the boundary of Ω1 as t → ∞, then the solutions of E1 do not escape
through the boundaries. Therefore, there exists some η = min{ηs, ηl, ηh, ηt} such that
lim inf
t→∞
xi(t) ≥ η for all i = 1, 2, 3, 4.
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This completes the proof
3.6 Existence and Uniqueness of the Endemic Steady
State
The endemic equilibrium E∗1 = (S
∗, L∗, H∗, T ∗) of the equation (3.2) satisfies
0 = π − β
(
L∗ + η1H
∗ + η2T
∗
N∗
)
S∗ − µS∗ + γ1L
∗,
0 = β
(
L∗ + ηH∗ + η2T
∗
N∗
)
S∗ + γ2H
∗ −Q1L
∗,
0 = σL∗ + γ3T
∗ −Q2H
∗,
0 = ρH∗ −Q3T
∗.
(3.18)
An endemic equilibrium E∗1 = (S
∗, L∗, H∗, T ∗) satisfies S∗, L∗, H∗, T ∗ > 0. Let A be the
matrix of transition states.
A =


−Q1 γ2 0
σ −Q2 γ3
0 ρ −Q3

 . (3.19)
The 3×3matrix (−A) with entries aij is anM-matrix and satisfies the following properties.
1. aij > 0 for i = j
2. aij ≤ 0 for i, j = 1, 2, 3
3. (−A) is non singular and (−A)−1 > 0. We note that (−A)−1 is positive definite and
therefore all the eigenvalues of (−A)−1 are positive.
4. There exist α > 0, such that (−A)−1x ≥ αx for x ≥ 0, [37].
After some tedious row reduction, the inverse of (−A) can be found and is non negative.
(−A)−1 =


Q2Q3(1−Φ1)
Q1Q2Q3(1−Φ1−Φ2)
γ2Q3
Q2Q3Q1(1−Φ1−Φ2)
γ2γ3
Q1Q2Q3(1−Φ1−Φ2)
σQ3
Q1Q2Q3(1−Φ1−Φ2)
Q1Q3
Q1Q2Q3(1−Φ1−Φ2)
Q1γ3
Q1Q2Q3(1−Φ1−Φ2)
ρσ
Q1Q2Q3(1−Φ1−Φ2)
ρQ1
Q1Q2Q3(1−Φ1−Φ2)
Q1Q2Q3(1−Φ2)
Q1Q2Q3(1−Φ1−Φ2)

 . (3.20)
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To show uniqueness of the endemic steady state (Theorem. 3.6.1), we follow closely the
formulation for the staged-progression model in [37]. Using property 4. of the M-matrices,
it follows that
ϕ = −(β, βη1, βη2)A
−1(1, 0, 0)t > 0, (3.21)
and
φ = −(1, 1, 1)A−1(1, 0, 0)t > 0, (3.22)
where (·)t denotes matrix transpose.
Theorem 3.6.1. Suppose that the function f satisfies the conditions (P1)−(P3) in section
3.2.1. If R0 ≤ 1, the only steady state in Ω1 is E0. If R0 > 1, the endemic steady state E
∗
1
exists in the interior of Ω1 and is unique.
Proof. It is enough to prove that a unique endemic equilibrium E1 exist if and only if
R0 > 1. We show this by writing the drug using classes in equation (3.18) in the form
(L∗, H∗, T ∗)t = −Λ∗S∗A−1(1, 0, 0)t. (3.23)
From equation (3.23), we observe that L∗, H∗ and T ∗ can be uniquely determined from S∗.
Pre-multiplying the row vector (β, βη1, βη2) of the contribution of each drug using class
with equation (3.23), we obtain
(β, βη1, βη2)(L
∗, H∗, T ∗)t = −(β, βη1, βη2)Λ
∗S∗A−1(1, 0, 0)t. (3.24)
We now use the general initiation function Λ∗ = f(N∗)β(L∗ + η1H
∗ + η2T
∗) and equation
(3.21), to obtain
β(L∗ + η1H
∗ + η2T
∗) = ϕS∗f(N∗)β(L∗ + η1H
∗ + η2T
∗). (3.25)
Since β(L∗ + η1H∗ + η2T ∗) 6= 0, it is clear that
ϕS∗f(N∗) = 1. (3.26)
Similarly , pre-multiplying the row vector (1,1,1) on both sides of (3.23) and applying the
initiation function, we obtain
(L∗ +H∗ + T ∗) = (1, 1, 1)(L∗, H∗, T ∗)t = φpf(N∗)S∗β(L∗ + η1H
∗ + η2T
∗). (3.27)
From the first equation of (3.18)
f(N∗)β(L∗ + η1H
∗ + η2T
∗)S∗ = π − µS∗. (3.28)
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This together with equation (3.27) implies that
S∗f(φπ + (1− φµ)S∗) =
1
ϕ
. (3.29)
We now show that, the equation (3.29) has a unique positive solution in the interval (0, π
µ
)
when R0 > 1. We use the function
y = g(S∗) = S∗f(φπ + (1− φµ)S∗). (3.30)
Clearly g(0) = 0 and g(Π
µ
) = π
µ
f
(
π
µ
)
g
′
(S∗) = f(φπ + (1− φµ)S∗) + (1− φµ)S∗f
′
(φπ + (1− φµ)S∗), (3.31)
= f(N∗) +N∗f
′
(N∗)− πφf
′
(N∗), (3.32)
= f(N∗) + (1− φµ)S∗f
′
> 0. (3.33)
Therefore, y = g(S∗) is monotonically increasing and the graph of g(S∗) has at most one
point of intersection with the line y = 1
ϕ
.
We can explicitly compute the endemic equilibrium by setting the left hand side of the
system of equations (3.2) to zero. From the last two equations of the resulting system, we
obtain
T ∗ =
ρ
Q2
H∗ , (3.34)
L∗ =
Q3
σ
(1− Φ1)H
∗. (3.35)
Adding the first two equations of the system (3.2) equated to zero, we obtain
π − µS∗ + γ2H
∗ −Q1L
∗ = 0. (3.36)
We now substitute equation (3.35) in (3.36), to obtain
H∗ = µ
(
π
µ
− S∗
)
σ
Q1Q3
[
1
1− (Φ1 + Φ2)
]
. (3.37)
Substituting (3.34) and (3.35) in the second equation of (3.2) equated to zero, we obtain
H∗ = 0 which corresponds to the drug free equilibrium(
π
µ
, 0, 0, 0
)
,
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and
H∗ =
σQ2S
∗(R0 − 1)
[Q2Q3(1− Φ1) + σQ2 + ρσ]
. (3.38)
Equating (3.38) and (3.37), and simplifying the resulting expressions, we get the drug-
persistent steady state expression,
E
∗
1 = (S
∗, L∗, H∗, T ∗),
where
S∗ =
π[Q2Q3(1− Φ1) +Q2σ + ρσ]
Q1Q2Q3(R0 − 1)[1− (Φ1 + Φ2)] + µ[Q2Q3(1− Φ1) +Q2σ + ρσ]
, (3.39)
H∗ =
σQ2S
∗(R0 − 1)
[Q2Q3(1− Φ1) +Q2σ + ρσ]
, (3.40)
L∗ =
Q2(1− Φ1)S
∗(R0 − 1)
[Q2Q3(1− Φ1) +Q2σ + ρσ]
, (3.41)
T ∗ =
σS∗(R0 − 1)
[Q2Q3(1− Φ1) +Q2σ + ρσ]
. (3.42)
We thus have the following result;
Theorem 3.6.2. The system (3.2) has a unique drug-persistent steady state when R0 > 1.
3.7 Local Stability of the Endemic Steady State
We use the center manifold theory described in [16] to check local stability of the endemic
steady state. Let us consider the system of equations (3.2) with the bifurcation parameter
φ such that
dx
dt
= f(x, φ), f : R4 × R→ R and f ∈ C2(R4 × R). (3.43)
Assume that 0 is a non-hyperbolic steady state of system (3.2), then f(0, φ) = 0 for all φ.
Let the linearisation matrix, A be such that
A = Dxf(0, 0), (3.44)
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has a left eigenvector denoted by y and the right eigenvector denoted by v. Then the local
dynamics of the model around 0 is totally governed by a and b [16, 71], where
a =
∑
k,i,j=1
ykvivj
∂2fk
∂xi∂xj
(0, 0) (3.45)
b =
∑
k,i,j=1
ykvi
∂2fk
∂xi∂φ
(0, 0) (3.46)
According to [16], the local dynamics of the model around 0 is determined by the signs of
a and b. We detail the condition on the signs of a and b and the bifurcation parameter
for convenience of interpretation of the stability.
i. a > 0, b > 0, when φ < 0 with |φ| ≪ 1, 0 is locally asymptotically stable, and there
exists a positive unstable equilibrium; when 0 < φ≪ 1, 0 is unstable and there exists
a negative and locally asymptotically stable equilibrium.
ii. a < 0, b < 0, when φ < 0 with |φ| ≪ 1, 0 is unstable; when 0 < φ≪ 1, 0, is locally
asymptotically stable, and there exists a positive unstable equilibrium.
iii. a > 0, b < 0, when φ < 0 with |φ| ≪ 1, 0 is unstable, and there exists a locally
asymptotically stable negative equilibrium; when 0 < φ ≪ 1, 0 is stable and a
positive unstable equilibrium appears.
iv. a < 0, b > 0, when φ changes from negative to positive, 0 changes its stability
from stable to unstable. Correspondingly, a negative unstable equilibrium becomes
positive and locally asymptotically stable.
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Let us now redefine the variables (S, L,H, T ) as (x1, x2, x3, x4). Then the system (3.2) can
be rewritten as
dx1
dt
= f1 = π − β
(
x2 + η1x3 + η2x4∑4
i=1 xi
)
− µx1 + γ1x2, (3.47)
dx2
dt
= f2 = β
(
x2 + η1x3 + η2x4∑4
i=1 xi
)
+ γ2x3 −Q1x2, (3.48)
dx3
dt
= f3 = σx2 + γ3x4 −Q2x3, (3.49)
dx1
dt
= f4 = ρx3 −Q3x4. (3.50)
We evaluate the bifurcation parameter φ by equating R0 to one to obtain
φ = β∗ =
Q1Q2Q3[1− (Φ1 + Φ2)]
Q2Q3(1− Φ1) + ησQ3 + η2ρσ
. (3.51)
We linearise the system of equations (3.2) at the drug free equilibrium and with the bifur-
cation parameter φ to obtain
J =


−µ −(β∗ − γ1) −β
∗η1 −β
∗η2
0 β∗ −Q1 β
∗η1 + γ2 β
∗η2
0 σ −Q2 γ3
0 0 ρ −Q3

 . (3.52)
The matrix (3.52) has left eigenvectors y = (y1, y2, y3, y4), where
y1 = 0,
y2 = Q2Q3(1− Φ1),
y3 = (β
∗η1 + γ2)Q3 + β
∗η2ρ,
y4 = γ3(β
∗η1 + γ2) + β
∗η2Q2.
The right eigenvector associated with the zero eigenvalue of (3.52) is v = (v1, v2, v3, v4)
where
v1 = Q1Q2Q3(1− Φ1 − Φ2)
[
γ1(1− Φ1)
Q1(1− Φ1 − Φ2)
− R∗0
]
, v2 = µQ2Q3(1− Φ1), (3.53)
v3 = µσQ3, v4 = µσρ, (3.54)
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where
R∗0 =
β∗ [Q2Q3(1− Φ1) + η1σQ3 + η2σρ]
Q1Q2Q3(1− Φ1 − Φ2)
.
We now evaluate the non-zero second order mixed derivatives of with respect to the vari-
ables where we obtain
∂2f1
∂x2∂x3
=
∂2f1
∂x3∂x2
= β
(1 + η1)µ
π
,
∂2f1
∂x2∂x4
=
∂2f1
∂x4∂x2
= β
(1 + η2)µ
π
, (3.55)
∂2f1
∂x3∂x4
=
∂2f1
∂x4∂x3
= β
(η1 + η2)µ
π
,
∂2f2
∂x2∂x3
=
∂2f2
∂x3∂x2
= −β
(1 + η1)µ
π
, (3.56)
∂2f2
∂x2∂x4
=
∂2f2
∂x4∂x2
= −β
(1 + η2)µ
π
,
∂2f2
∂x3∂x4
=
∂2f2
∂x4∂x3
= −β
(η1 + η2)µ
π
. (3.57)
The non-zero partial derivatives to used in calculating b are
∂2f1
∂x2∂φ
= −1,
∂2f2
∂x2∂φ
= 1, (3.58)
∂2f1
∂x3∂φ
= −η1,
∂2f2
∂x3∂φ
= η1, (3.59)
∂2f1
∂x4∂φ
= −η2,
∂2f2
∂x4∂φ
= η2. (3.60)
We now substitute the expressions into (3.45) and (3.46) to obtain
a = −
2β∗µy2
π
[v2v4(1 + η2) + v2v3(1 + η1) + v3v4(η1 + η2)] ,
b = µQ2Q3(1− Φ1) [Q2Q3(1− Φ1) + η1σQ3 + η2σρ] .
Clearly, we observe that a < 0 and b > 0. Thus, the drug persistent steady state is locally
asymptotically stable close to R0 = 1. We can summarise the results in the following
theorem.
Theorem 3.7.1. The drug persistent steady state is locally asymptotically stable when
R0 > 1 but only if R0 is close to 1.
3.7.1 Global Stability of the Drug Persistent Steady State
In this section, we now prove the global stability of the drug persistent steady state.
Theorem 3.7.2. The unique drug-persistent equilibrium E∗1 is globally asymptotically sta-
ble if R0 > 1.
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Proof. We propose a lyapunov function W such that
V =
(
S − S∗ − S∗ ln
S
S∗
)
+ α1
(
L− L∗ − L∗ ln
L
L∗
)
+ α2
(
H −H∗ −H∗ ln
H
H∗
)
+ α3
(
T − T ∗ − T ∗ ln
T
T ∗
)
,
(3.61)
where α1, α2 and α3 are positive constants to be determined. We note that V (x) ≥ 0 for
x ∈ Int Ω1, the interior of Ω1 and V (x) = 0 if and only if x = x∗. Then V (x) is positive
definite with respect to drug persistent equilibrium x = E∗1.
The function is continuous for all S, L,H, T > 0. We note that (3.61) satisfies the following;
∂V
∂S
=
(
1−
S∗
S
)
,
∂V
∂L
= α1
(
1−
L∗
L
)
,
∂V
∂H
= α2
(
1−
H∗
H
)
,
∂V
∂T
= α3
(
1−
T ∗
T
)
.
(3.62)
Taking the second partial derivative of each of the terms in (3.62), we can say that E∗1 is
the only extremum and global minimum of R4+. Note that in [37], the coefficients to the
Lyapunov function of a similar model were obtained by a recursive method. In this thesis,
we use a slightly different approach. The corresponding time derivative of the lyapunov
function is given by
dV
dt
=
(
1−
S∗
S
)
S˙ + α1
(
1−
L∗
L
)
L˙+ α2
(
1−
H∗
H
)
H˙ + α3
(
1−
T ∗
T
)
T˙ . (3.63)
We note that the system of equations (3.2) at the endemic steady state satisfy.
π = µS∗ + Λ∗S∗ − γ1L
∗,
Q1L
∗ = Λ∗S∗ + γ2H
∗,
Q3T
∗ = ρH∗,
Q2H
∗ = σL∗ + γ3T
∗.
(3.64)
We Set E∗1 = (S
∗, L∗, H∗, T ∗) ∈ Ω1 ⊂ R
4
+. Using (3.2) and (3.64) it can easily be shown
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that. (
1−
S∗
S
)
S˙ =
(
1−
S∗
S
)
[π − Λ∗S∗ − µS∗ + γ1L
∗] ,
=
(
1−
S∗
S
)
[µS∗ + β(L∗ + η1H
∗ + η2T
∗)S∗ − γ1L
∗
−β(L+ η1H + η2T )S − µS + γ1L] ,
= µS∗
(
2−
S
S∗
−
S∗
S
)
− γ1L
∗
(
1−
L
L∗
)(
1−
S∗
S
)
+ βS∗
(
1−
S∗
S
)[
L∗
(
1−
SL
S∗L∗
)
+ η1H
∗
(
1−
SH
S∗H∗
)]
(3.65)
+ βη2S
∗T ∗
(
1−
S∗
S
)(
1−
ST
S∗T ∗
)
.
From equation (3.65), using the arithmetic-geometric means inequality, it is clear that
µS∗
(
2−
S
S∗
−
S∗
S
)
≤ 0. (3.66)
Note that equality holds at the endemic steady state. Similarly, using equations (3.2) and
(3.64), the remaining components of (3.63) can be found as
α1
(
1−
L∗
L
)
L˙ = α1βS
∗
(
1−
L∗
L
)[
L∗
(
SL
S∗L∗
−
L
L∗
)
+ η1H∗
(
SH
S∗H∗
−
L
L∗
)]
+ α1
(
1−
L∗
L
)[
βη2S
∗T∗
(
ST
S∗T ∗
−
L
L∗
)
+ γ2H
∗
(
H
H∗
−
L
L∗
)]
,
(3.67)
α2
(
1−
H∗
H
)
H˙ = α2
(
1−
H∗
H
)[
σL∗
(
L
L∗
−
H
H∗
)
+ γ3T
∗
(
T
T ∗
−
H
H∗
)]
, (3.68)
α3
(
1−
T ∗
T
)
T˙ = α3
(
1−
T ∗
T
)(
H
H∗
−
T
T ∗
)
ρH∗. (3.69)
Using the third and fourth equations of (3.64), we obtain
L∗ =
(Q2Q3 − ργ3)
ρσ
T ∗. (3.70)
We now let
(
S
S∗
, L
L∗
, H
H∗
, T
T ∗
)
= (U,W,X, Y ). Using this and the substitution of (3.70) into
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(3.65) and (3.68), equation (3.63) then becomes
dV
dt
≤ βS∗L∗
[(
1−
1
U
)
(1− UW ) + α1
(
1−
1
W
)
(UW −W )
]
+ βη1S
∗H∗
[(
1−
1
U
)
(1− UX) + α1
(
1−
1
W
)
(UX −W )
]
+ βη2S
∗T ∗
[(
1−
1
U
)
(1− UY ) + α1
(
1−
1
W
)
(UY −W )
]
+ T ∗
[
α1
(
1−
1
W
)
(X −W )
Q3γ2
ρ
+ α2
(
1−
1
X
)
(W −X)
(Q2Q3 − ργ3)
ρ
]
+
[
α2γ3
(
1−
1
X
)
(Y −X) + α3Q3
(
1−
1
Y
)
(X − Y )
]
T ∗ (3.71)
−
γ1
ρσ
(Q2Q3 − ργ3)(1−W )
(
1−
1
U
)
T ∗.
In order to eliminate the coefficients of W , X and Y , we choose the coefficients α1, α2 and
α3 such that
α1 = 1, α2 =
Q3γ2
(Q2Q3 − ργ3)
, α3 =
γ2γ3
(Q2Q3 − ργ3)
(3.72)
Substituting the coefficients (3.72) into (3.71) we obtain
dV
dt
≤ βS∗L∗f1(U) + βη1S
∗H∗f2(U,W,X) + βη2S
∗T ∗f3(U,W, Y ) (3.73)
+ f4(U,W,X, Y ) + f5(U,W )
Such that
f1(U) =
(
2−
1
U
− U
)
, (3.74)
f2(U,W,X) =
(
2−
1
U
−
UX
W
+X −W
)
, (3.75)
f3(U,W, Y ) =
(
2−
1
U
−
UY
W
+ Y −W
)
, (3.76)
f4(U,W,X, Y ) = −
[
Q3γ2γ3
(Q2Q3 − ργ3)
(Y −X)2
XY
+
Q3γ2
ρ
(X −W )2
XW
]
T ∗, (3.77)
f5(U,W ) = −
γ1
ρσ
(Q2Q3 − ργ3)(1−W )
(
1−
1
U
)
T ∗. (3.78)
From function (3.74), using the arithmetic-geometric means inequality, f1 is less or equal
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to zero with equality only when U = 1. The functions f2 and f3 can be simplified into
f2(U,W,X) =
(
2−
1
U
− U
)
−
(X −W )(U −W )
W
, (3.79)
f3(U,W, Y ) =
(
2−
1
U
− U
)
−
(Y −W )(U −W )
W
. (3.80)
After some algebraic manipulation and using arithmetic-geometric means inequality, we
can show that expressions f2, f3 and f5 are less or equal to zero with equality only at
the endemic steady state. We also note that from equation (3.66), since µS∗ 6= 0, then(
2− S
S∗
− S
∗
S
)
= 0 only if S = S∗. This corresponds to the susceptible population at the
endemic steady state. Similarly, at the endemic steady state
Λ = Λ∗, H = H∗, L = L∗, T = T ∗ (3.81)
Substituting S = S∗ and (3.81) into (3.73), we obtain
dV
dt
≤ 0, (3.82)
where the only compact invariant subset of Ω1 where equality holds (dV/dt = 0) is the
singleton {E∗1}. By the LaSalle Invariance Principle [15], E
∗
1 is globally asymptotically
stable in the interior of Ω1. This completes the proof.
3.8 Sensitivity Analysis
In this section we carry out sensitivity analysis to find out the contribution of some vi-
tal parameters to the dynamics of the model and ascertain unprecedented behaviour of
the model if such input parameters are varied. This helps us to allot qualitatively and
quantitatively, the variation in the output of the mathematical model to different input
variables. Various methods such as differential sensitivity analysis, one-at-a-time sensitivity
measures, factorial design, sensitivity index, importance factors, and subjective sensitivity
analysis [38], have been used to carry out sensitivity analysis. Of all these methods, sub-
jective sensitivity analysis is the only qualitative method and it relies on the opinion of
experienced investigators [38]. In this thesis, we use sensitivity indices by determining the
relative change in the reproduction number when a model parameter changes. We use the
normalised forward sensitivity index of the reproduction number to the model parameters
described in [19, 38]. This is defined as the relative change in the variable R0 to the relative
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change in the parameter. We let R0 be a differentiable function of each of the parameters.
Definition 3.8.1. Let R0 be a differentiable function on the parameter ̺, then the nor-
malised forward sensitivity index of R0 at ̺ is defined as
ΥR0̺ =
∂R0
∂̺
×
̺
R0
. (3.83)
The quotient ̺
R0
, is introduced to normalise the coefficient by removing the effect of units.
In addition, this calculation is based on the assumption that higher order partial derivatives
are negligible and that no correlation exists between input parameters [38]. We now use
the explicit formula for R0 in (3.7) and the definition (3.83), to evaluate the analytical
expressions for sensitivity of R0, to the parameters described in Table. 3.2. For example
the sensitivity index of R0 to the contact rate β is given as
ΥR0β =
∂R0
∂β
×
β
R0
= 1. (3.84)
Clearly, the normalised forward sensitivity index (NFSI) with respect to β does not depend
on any of the parameter values. However, we note that increasing the contact is directly
proportional to R0 and therefore increasing β by 2% increases R0 by the same percentage.
Increase in the contact rate consequently increases prevalence of substance abuse, see Figure
3.6. The indices of relative initiation rates of heavy users and drugs users on treatment
have obvious structures respectively as
ΥR0η1 = 1−
Q2Q3(1− Φ1) + ρη2σ
Q2Q3(1− Φ1) + η1σQ3 + ρη2σ
, (3.85)
ΥR0η2 = 1−
Q2Q3(1− Φ1) + η1σQ3
Q2Q3(1− Φ1) + η1σQ3 + ρη2σ
. (3.86)
The rest of the expressions of normalised forward sensitivity indices are complex. Therefore,
we evaluate the indices of all the rest of the parameters at the nominal values and give the
corresponding results in Table. 3.2. The sign of the calculated value indicates whether,
the parameter increases the reproduction number (positive sign) and consequently the
prevalence, or reduces the reproduction number (negative sign) and hence the prevalence.
Based on the nominal parameter values, the sensitivity indexes of parameters β, η1, η2,
σ and γ3 are positive. The magnitude of the NFSIs of these parameters indicates that,
R0 is more sensitive to changes in β (NFSI=1). The parameters µ , γ1, γ2, ρ, δ1, δ2 and
Stellenbosch University http://scholar.sun.ac.za
Chapter 3. 51
k have negative NFSIs and therefore increasing such parameters reduces R0. Of all such
parameters γ1 with |NFSI| = 0.56 is the most sensitive .
3.9 Numerical Simulations
3.9.1 Parameter Estimation
Natural mortality rate µ: The average life expectancy of Sub-Saharan Africa is 50 years
[1] and the corresponding mortality rate is thus 0.02 per year.
Drug related removal rates δ1 and δ2. The time people engage in high risk behaviour
under the influence of drugs is not known, and probably varies between populations [41].
Therefore, precise estimation of mortality/removal rates related to substance abuse remains
a relatively daunting task. In [13], mortality rates related to drugs among crank-cocaine
users and injecting drug users are 0.018 and 0.008 respectively. According to [70], a man
who stops smoking at 35 years of age can increase his life expectancy by 5 years. We
assume a reduction in life expectancy of 14% due to general substance abuse. With the
corresponding µ = 0.02yr−1, the mortality rate of heavy users related to substance abuse δ1
is 0.0028yr−1. Noting that treatment improves the quality of life, we assume that treatment
reduces mortality rate related to drugs by at-least 50%. Thus, we choose δ2 = 0.0014yr−1.
Progression rate σ. In [17], the progression rate from light use to heavy use is 0.47. This
incorporates progressions from light use to moderate use and then escalation heavy use. On
the other hand, the value used was 0.024 [5], and between (0.003, 0.004) in [71] specific to
methamphetamine users. In three major cities in South Africa 54% of arrestees who tested
positive for cannabis had used the drug in the past 30 days. We may assume that all these
arrestees had been heavy cannabis users. We can therefore choose a general progression
rate of 0.56 per annum.
Recruitment into rehabilitation ρ. Individuals to be put under rehabilitation must meet the
Diagnostic and Statistical Manual of Mental Disorder-Fourth Edition (DSM- IV) criteria for
substance abuse or substance dependence. in the survey results from at least 80% specialist
substance abuse treatment centres, it was observed that the proportion of patients under
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the age of 20 years from January 1997 to December 2001, increased from 5.5% to 24.1% and
from 7.0% to 22.0% in Cape Town and Durban respectively. In Gauteng, the proportion
increase from 9.9% to 23.4% since the between 1998− 2001 [74]. The observed treatment
demand for cannabis users is 17% [77]. There was an observed increase in cannabis use in
the first two quarters of 2008 in South Africa, and including alcohol, the observed treatment
demand for cannabis accounted for 23.5% of all substance abuse [97]. According to [96]
treatment of drug users accounted for 20% of all Medicare hospitalisations. We assume
this value corresponds to the treatment demand. In [71], the upper limit of the treatment
demand (0.009, 0.3) for methamphetamine users corresponds to 30% treatment rate. In
this paper, we choose the average treatment demand of 22.3% with the corresponding
treatment rate of 0.223.
Parameter Nominal value Range Source Sensitivity Index
β 0.105 0.10-0.21 [71] 1
η1 0.8 0-1 Estimated +0.39
η2 0.6 0-1 Estimated +0.14
π 0.040 0.028-0.080 Estimated
µ 0.020 0.019-0.021 [1] -0.14
σ 0.560 0.400-0.700 Estimated +0.15
γ1 0.200 0.10-0.6 Estimated -0.56
γ2 0.20 0.20-0.50 Estimated -0.13
γ3 0.25 0.10-0.30 Estimated +0.12
ρ 0.223 0.17 -0.30 Estimated -0.20
δ1 0.003 0.0015-0.0035 Estimated -0.01
δ2 0.002 0.0013 -0.002 Estimated -0.002
k 0.20 0.15-0.50 Estimated -0.22
Table 3.2. Parameter values used in simulations and sensitivity analysis
3.9.2 Prevalence and Incidence of Substance Abuse
Prevalence of substance abuse is a mathematical quantity that describes the level of sub-
stance abuse in the population. It indicates the proportion of persons in the population
who are substance users. This is summarised as
Prevalence =
Number of drug users in the population at a given time
Total population (N)
.
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Therefore, prevalence of substance abuse is a measure of the burden of substance abuse in
the population.
The incidence of substance abuse is given as a mathematical quantity describing the oc-
currence of new drug users in the population within a given period of time. This can be
summarised as
Incidence =
Number of new drug users in the population N at a time t
Total population N
.
If we view substance abuse as a disease with low cure rate and as a disease where rehabil-
itation permits long term survival of drug users, then we can reliably claim that incidence
will contribute to growth of prevalence. On the other hand, if control measures are put
in place to accelerate quitting and increase the removal of drug users from drug using
compartments such that the removal rate exceeds the incidence rate, then prevalence will
reduce otherwise, prevalence will continuously grow.
(a) (b)
Figure 3.3. Graphical representation of estimated (a) prevalence, (b) incidence.
These two important epidemiological terms are related by the expression given in [2]
prevalence odds = Incidence × Duration,
and is frequently taken to hold for stationary populations.
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Figure 3.4. Population trajectory when R0 = 0.834 < 1. When R0 < 1, the subsequent
generation of drug users is lower than, their predecessors, therefore drug use is consequently
eliminated from the population.
Figure 3.5. Population trajectory when R0 = 1.189 > 1. When R0 is greater than unity,
the subsequent generation of drug users is greater than their predecessors. Therefore,
substance abuse persists in the population.
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3.9.3 Contribution of amelioration, rehabilitation and relapse
In this subsection, we present numerical results showing the impact of some key parameters
in drug epidemics. The contribution of amelioration, rehabilitation and relapse is modelled
through the parameters γ2, ρ and γ3 respectively.
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Figure 3.6. Effect of contact rate β on prevalence of substance abuse
(a) (b)
Figure 3.7. Shows the impact of amelioration on prevalence of substance abuse: (a) indi-
cates that, amelioration in presence of quitting for light users (γ1 = 0.2) reduces prevalence
whereas, (b) amelioration in absence of quitting for light (γ1 = 0) increases the prevalence
of substance abuse.
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To investigate the contribution of contact, we vary the values of contact rate i.e β =
{0.14, 0.18, 0.20, 0.21} and obtain the corresponding plots of prevalence in the population
evolving over time, Figure 3.6. The respective values of the reproduction number obtained
are, R0 = {0.94, 1.20, 1.34, 1.41}.We note from the obtained values that, a unit increase in
contact rate β, increases the reproduction number, R0 by six folds and hence the prevalence
of substance abuse. The increase in Prevalence is due to the fact that; if the number of
contacts (c) is kept constant, increased contact rate (β = cβˆ) increases the probability (βˆ)
that a contact will result into an individual being initiated. In Figure 3.7, the shaded part
is the contribution of amelioration in increasing or decreasing prevalence. We observe that
quitting of light users has implications in drug control strategies as early identification has
positive results.
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Figure 3.8. Shows the impact of rehabilitation and re-initiation on the prevalence of sub-
stance abuse
We observe the changes in prevalence as re-initiation/relapse rate changes. Leaving the
other parameters constant, we present some different relapse rates from 15% to 30% and
indicate the different scenarios of prevalence curves in Figure 3.8(b). The reproduction
number is observed to increase from 1.4387 to 1.5436 (this is consistent with the corre-
sponding positive normalised forward sensitivity index in Table. 3.2) and substance abuse
prevalence increases from approximately 30.5% to 35.1%. This indicates that, on average a
15% increase in re-initiation increases the prevalence of substance abuse by approximately
5%. This increase in prevalence with relapse is due to relapse creating cycling of drug
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users, who in turn contribute to the initiation process.
Varying the rehabilitation/treatment coverage to a level of 17% to 30% to find out the
group of drug users to be targeted and make rehabilitation more effective, the reproduc-
tion number is observed to reduce from 1.44 to 1.28 and consequently prevalence reduces
from approximately 30.4% to 21.8%, Figure 3.8(a). Therefore, keeping other parameters
constant, a unit percentage increase in rehabilitation/treatment of problematic drug users
results in approximately 0.66% decrease in prevalence.
3.10 Summary
The model is designed and used to study the dynamics of substance abuse in the population.
The heterogeneous population has been classified into homogeneous classes with relatively
equal frequency of substance abuse. The model incorporates removal rates related to
substance abuse mainly for the drug users at acute/chronic levels of problematic drug use.
Sensitivity analysis of the threshold number on the model parameters has been done to
identify the vital parameters that influence prevalence of substance abuse. Below are the
results of our study on this model with amelioration.
1. The model considered in this study has a globally asymptotically stable drug free
steady state whenever R0 < 1. Therefore, substance abuse can be eliminated if con-
trol measures are put in place and efforts are directed towards reducing the threshold
number to a value less than unity. Otherwise, if R0 > 1, the drug free steady state
is unstable and the drug persistent steady state globally stable. Hence, substance
abuse remaining endemic in the population.
2. Based on the numerical results and sensitivity analysis, substance abuse can be re-
duced by; reducing the contact rate β, the relative initiation rates η1 and η2, the
re-initiation rate γ3 and the the progression rate σ. These parameters have positive
normalised sensitivity indices, as indicated in Table 3.2. The rest of the parameters
with negative normalised sensitivity indices have a more dominant inverse propor-
tionality with R0. Therefore, efforts resulting in increase of such parameters, reduce
the prevalence of substance abuse.
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3. Amelioration is observed to reduce the prevalence of substance abuse, see Figure
3.7(a). The numerical results with amelioration are consistent with the normalised
sensitivity index value in Table 3.2. This is possible because the model incorporates
quitting for light users γ1. On the other had, if there is no quitting for light users
in the model, amelioration creates cycling of drug users, thus increasing prevalence,
see Figure 3.7(b). A similar observation to that of amelioration without quitting for
light users was obtained in [84].
4. Treatment and rehabilitation is aimed at improving the quality of life. The program
also results in some drug users quitting which reduces the prevalence of substances
abuse. However, due to withdrawal symptoms, partial re- initiation/relapse is ob-
served. The amount of substance required when relapsing is approximately the same
as that of a heavy using class. Therefore, relapsing users return directly to heavy
drug use.
5. In the model, the vital parameters must depend on factors such as age, behaviour, so-
cial economic status, occupation, spatial position or stage of the epidemic. Treatment
is applied at the chronic level of substance abuse when rehabilitation is paramount
and presumed vital in accelerating quitting hence reducing the prevalence of sub-
stance abuse, see Figure 3.8(a).
In our model we did not stratify the population according to age. However, we acknowl-
edge the fact that different age groups have different drug using patterns and individuals
start using drugs at ages below 15 years, although drug use is much more incident from
ages above 15. Therefore, structuring the population in terms of age would give better
conclusions on how to control drug epidemics.
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Influence of Drug Barons on the
Prevalence of Substance Abuse.
4.1 Introduction
Substance abuse accounts for most of the criminal offences in townships and cites in South
Africa [75]. These offences associated with alcohol and illicit drugs use include; possession
and sale of illicit drugs, crime to obtain money to purchase drugs and quench drug addic-
tion, driving under the influence of drugs, child abuse and domestic violence among others.
At the heart of the dynamics of illicit drug use patterns is a special class of individuals
called drug lords. The drug lords, also commonly known as drug barons or kingpins, are
individuals who command a sizeable network of individuals involved in illegal trading of
drugs. They play a huge role in shaping drug use patterns over time. The patterns are
also influenced by progression of users through different drug use states [17]. We use a
compartmental model to ascertain the contribution of drug lords, as well as the impact of
law enforcement on drug epidemics.
4.2 The Model with Drug Lords
We extend the model given in Chapter 3, by incorporating a compartment of drug lords D.
We assume that the drug lords contribute to the initiation into drug use by acting as drug
59
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supply chains, and making potential drug users aware of the availability of the drugs. In
our model, we also assume that drug lords are not drug users basing on the assumption that
if they are to use substances, they may end up giving out drugs free of charge as they may
be intoxicated. The population of drug lords increases due to the increase in the number
of drug users following the law of demand and supply. In the model, we suppose that, in
addition to natural mortality, drug lords are also removed as a result of law enforcement
or failure to compete in the market. We propose a per capita removal rate function h(r)
such that the removal of drug lords occurs at a rate h(r)D. In this chapter we shall define
the removal rate function as
h(r) =

r for D > 00 for D = 0
Similar to the epidemic model with constant removal rate in [103], r > 0 implies that law
enforcement is kept in full force until the population of drug lords is remarkably reduced
to such a value that substance abuse can be eliminated from the community.
The presence of drugs lords changes the force of initiation from Λ (presented in Chapter
3) to a new value Λ¯ given by
Λ¯ = Λ + α1D.
Drug lords however, exist as an entity that is not usually part of the community. They act
as an environment that influences drug use in the community through supplying drugs to
potential users. Their influence in community is felt through organised or brutal syndicates
that do not accept non payment of supplies. We therefore do not include them as part of
the population N under consideration.
The purpose of this chapter is to determine the dynamics of the substance abuse model
analysed in Chapter 3, influenced by drug lords and law enforcement. The model diagram
Figure 3.1 is modified to include a compartment D. The flow diagram is represented by
Figure 4.2.
In this extended model the epidemiological parameters are all also constant. The descrip-
tion of these parameters other than those indicated in Table. 3.1, is given in the Table.
4.1 below:
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Figure 4.1. Flow diagram shows drugs use dynamics involving drug lords.
Parameter Description
α1 The effective contact rate between drug lords and the susceptible population. In this
interaction, we view the drug lords as the suppliers of drugs and the drug users as the
consumers. It is reasonable to note that, if D(t) = 0, also α1 = 0. Therefore, there
can be no use of drugs without access to drug although access can result into use [54].
α2 The fraction of light users whose presence contributes to the escalation of drug lords.
α3 The fraction of heavy users whose presence contributes to the escalation of drug lords.
r The removal rate of drug lords which constitutes mainly intervention from law
enforcement, community policing, the justice system and incarceration.
Table 4.1. Additional parameters used in the model with drug lords
The ordinary differential equations that represent the compartmental model are
S˙ = π + γ1L− ΛS − α1SD − µS,
L˙ = ΛS + α1SD + γ2H −Q1L,
H˙ = σL+ γ3T −Q2H,
T˙ = ρH −Q3T,
D˙ = α2L+ α3H −Q4D,
(4.1)
where
Q1 = (µ+ σ + γ1), Q2 = (µ+ ρ+ γ2 + δ1), Q3 = (µ+ γ3 + δ2 + k), Q4 = (µ+ r).
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4.3 Model Analysis
In this section, we establish some facts relating to long term behaviour of the solution to
the system of equations (4.1). We derive and investigate the stability of the equilibrium
states; the Drug Free Equilibrium (DFE) and the Drug Persistent Equilibrium (DPE). In
our analysis the phase space of (4.1) is based on the assumption that drug lords are not
drug users and are not directly involved dynamics of the total population of drug users
and the susceptible population. Since the population under consideration is influenced by
the population of drug lords, we denote our phase space in this chapter by Ω2 instead of
Ω1 used in Chapter 3. The phase space is therefore given by,
Ω2 = {S, L,H, T > 0 : S + L+H + T = N} . (4.2)
Lemma 4.3.1. For Ω2 defined by (4.2), we let x(t) denote the solution of (4.1) with initial
conditions x(0) ∈ Ω2, then x(t) ∈ Ω2 for all t > 0.
Proof. To see that the solution of the system (4.1) starting from any point in Ω2 remains
in Ω2, we use the total population of substance users N = S + L + H + T . The rate of
change of the total population is given by,
N˙ = π − µN − δ1H − δT ≤ π − µN. (4.3)
We now solve the differential inequality using a suitable integrating factor to obtain,
N ≤
π
µ
+
(
N0 −
π
µ
)
exp(−µt) for t ≥ 0.
If N0 <
π
µ
, the solution of the differential equation N = π − µN is monotone increasing
and bounded by π
µ
as t → +∞. Otherwise, the solutions are monotone decreasing and
bounded above if N0 >
π
µ
as t→ +∞. Therefore, the phase space becomes
Ω2 =
{
(S, L,H, T )|S + L+H + T ≤
π
µ
}
. (4.4)
Following a similar approach in [92], we consider a case in (4.1) when at-least one of the
phase space variables is equal to zero e.g L = 0, then L˙ ≥ 0. This means that the solution
trajectories of (4.1) do not go through the boundary of Ω2, forward in time. This condition
is valid for all phase space variables. Therefore, the phase space (4.4) is positively-invariant
and attracting under the flow induced by the system (4.1).
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4.3.1 The Basic Reproduction Number
We define the basic reproduction number R0UD as the expected number of secondary
initiations that result from introducing a single drug user and, or a drug baron in a purely
susceptible population. We use this R0UD as a fundamental quantity of our analysis to
determine the situation when substance abuse can be wiped out or remain prevalent in
the population. We use the next generation matrix approach described in [39, 84, 100] to
evaluate the basic reproduction number of the model. Then we have,
F =


β βη1 βη2 α1
π
µ
0 0 0 0
0 0 0 0
0 0 0 0

 , V =


Q1 −γ2 0 0
−σ Q2 −γ3 0
0 −ρ Q3 0
−α2 −α3 0 Q4

 .
The basic reproduction number is given as the spectral radius of the next generation matrix
FV −1 so that
R0UD = ρ(FV
−1) = R0U +R0D,
with
R0U =
β [Q2Q3(1− Φ1) +Q3η1σ + ρη2σ]
Q1Q2Q3 (1− (Φ1 + Φ2))
and R0D =
α1π [α2Q2(1− Φ1) + σα3]
µQ1Q2Q4 (1− (Φ1 + Φ2))
,
where
Φ1 =
ργ3
Q2Q3
and Φ2 =
σγ2
Q1Q2
.
The reproduction number R0UD is given in two parts indicating the contribution of two
different groups in the drug initiation process. The values R0U and R0D measure the
average number of new drug users who may be initiated into drug use if a drug user or
drug baron respectively is introduced in a purely susceptible population.
The term R0U (contribution of drug users) is the exact value of R0 obtained and explained
in Chapter 3. To describe the drug lords induced contribution to the reproduction number
R0D, we write R0D in the form
R0D = R
1
0D +R
2
0D,
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where
R10D =
α1πα2(1− Φ1)
µQ1Q4 (1− (Φ1 + Φ2))
and R0D =
σα1α3π
µQ1Q2Q4 (1− (Φ1 + Φ2))
.
The terms R10D and R
2
0D indicate the contribution in the initiation of drug users by drug
lords who escalated from the presence of light and heavy drug users respectively.
4.4 Drug Persistent Equilibrium
At the drug persistent equilibrium, the system satisfies
0 = π + γ1L
∗ − Λ∗S∗ − α1S
∗D∗ − µS∗, (4.5)
0 = Λ∗S∗ + α1S
∗D∗ + γ2H
∗ −Q1L
∗, (4.6)
0 = σL∗ + γ3T
∗ −Q2H
∗, (4.7)
0 = ρH∗ −Q3T
∗, (4.8)
0 = α2L
∗ + α3H
∗ −Q4D
∗. (4.9)
From equations (4.7) and (4.8) we have
H∗ = ξ1L
∗, where ξ1 =
σ
Q2(1− Φ1)
, (4.10)
T ∗ = ξ2L
∗, where ξ2 =
ρ
Q3
ξ1 and, (4.11)
D∗ = ξ3L
∗ where ξ3 =
α2Q2(1− Φ1) + α3σ
Q2Q4(1− Φ1)
. (4.12)
Using the substitution of equations (4.10) and (4.11) and expression for the initiation
function (3.1), the initiation function at the endemic equilibrium can be given by
Λ∗ = Ψ1
L∗
N∗
where Ψ1 = β(1 + η1ξ1 + η2ξ2).
This can also be given in terms of the component R0U of the reproduction number as
Λ∗ = Ψ2R0U
L∗
N∗
where Ψ2 =
Q1(1− (Φ1 + Φ2))
(1− Φ1)
.
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From equation (4.6)
Ψ1
L∗S
N∗
+ α1ξ3SL
∗ + γ2ξ1L
∗ −Q1L
∗ = 0,
L∗
[
Ψ1S
∗
N∗
+ α1ξ3S
∗ + γ2ξ1 −Q1
]
= 0.
Either L∗ = 0 or
S∗
(
Ψ1
N∗
+ α1ξ3
)
= Ψ2, Ψ2 > 0. (4.13)
Note that the initiation function Λ∗ is zero (Λ∗ = 0) when
L∗ = 0 ⇒ H∗ = T ∗ = 0, and S∗ =
π
µ
.
Consequently, the population of drug lords will reduce to low negligible values over time.
So we have the drug free equilibrium given as
DFE =
(
π
µ
, 0, 0, 0, 0
)
. (4.14)
Using equations (4.5) and (4.6), is can easily be shown that
S∗ =
π
µ
+ J1L
∗ where J1 =
γ1 −Ψ2
µ
. (4.15)
The total population can then be given as
N∗ = S∗ +Ψ3L
∗, (4.16)
=
π
µ
+ (J1 +Ψ3)L
∗ where Ψ3 =
Q2Q3(1− Φ1) + σQ3 + σρ
Q2Q3(1− Φ1)
. (4.17)
We now substitute for S∗ (4.15) and N∗ (4.17) in equation (4.13) to obtain
a2L
∗2 + a1L
∗ + a0 = 0, (4.18)
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where
a2 = α1ξ1J1(J1 + Ψ3) =
α1ξ1
µ
[
(γ1 −Ψ2)
2
µ
+Ψ3(γ1 −Ψ2)
]
,
a1 = (α1ξ3 −Ψ2)(J1 +Ψ3) + J1
(
Ψ1 +
α1ξ3π
µ
)
,
=
(γ1 −Ψ1)
µ2
[µΨ2(R0U − 1) + 2πα1ξ3] + γ2γ3(R0D − 1),
a0 =
π
µ
Ψ2 (R0UD − 1) .
Therefore, the solution to (4.18) will be given by
L∗{1,2} =
−a1 ±
√
a21 − 4a2a0
2a2
. (4.19)
We note that the signs of the coefficients a2 and a1 depend on the parameter values. To
determine the sign of a0 for different values of R0UD, we now analyse the term
(1−Φ1−Φ2)
1−Φ1
.
Note the term (1−Φ1) describes the movement of substance users who do not cycle between
the compartments H and T . The expression above can be re-written in the form
(1− Φ1 − Φ2)
1− Φ1
= 1−
Φ2
1− Φ1
If we suppose
Φ1
1− Φ2
< 1, then Φ1 + Φ2 < 1.
We now substitute for Φ1 and Φ2 to obtain
ργ3Q1 + σγ2Q3 < Q1Q2Q3.
We expand both sides and cancel common terms obtaining
0 < Q3(µ
2 + µγ2 + µδ1 + σδ1) + (µ+ δ1 + k)(µρ+ σρ+ µσ) + µσγ2.
Therefore, the term (1−Φ1−Φ2)
1−Φ1
is positive. Since (1− Φ1) > 0, also (1− Φ1 − Φ2) > 0.
The sign of a0 depends on the reproduction number; where a0 is positive (negative) when
R0UD is greater than (less than) unity. If a2 < 0, then the existence of feasible (positive)
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solutions will entirely depend on the signs of a0 and a1 as follows.
If a1 > 0, and

a0 > 0 we have one positive solutiona0 < 0 No positive solution
If a1 < 0, and

a0 > 0 we have one positive solutiona0 < 0 two positive solution
(4.20)
Our analysis for this case can be summarized into the following theorem;
Theorem 4.4.1. The drug epidemics model (4.1) has;
(I) a unique drug persistent equilibrium in Ω2 when a0 > 0 i.e R0UD > 1.
(II) two drug persistent equilibria in Ω2 if a1 > 0 and a0 < 0 i.e R0UD < 1.
(III) a unique drug persistent equilibrium in Ω2 when a0 = 0 and a1 > 0 or a
2
1 − 4a2a0.
(IV) no drug persistent equilibrium elsewhere.
On the other hand, if a2 < 0, then the a1 and a0 as indicated in (4.20) will reverse signs
and the system will not make sense epidemiologically.
It is clear from Theorem 4.4.1 case (I) that the model has a unique drug persistent equi-
librium whenever R0UD > 1. Furthermore, case (III) suggests the existence of a backward
bifurcation. If we set the discriminant to zero i.e
a21 − 4a2a0 = 0,
and the result is solved for the critical value of R0UD denoted by Rc0UD, we have
Rc0UD = 1 +
µa21
4a2πΨ2
, (4.21)
below which no drug persistent equilibrium exist.
4.4.1 Global Stability of the DFE
Theorem 4.4.2. The model system (4.1) has a globally asymptotically stable DFE when-
ever R0UD < R
c
0UD < 1.
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Proof. The condition R0UD < Rc0UD < 1, ensures existence of a unique drug free equilib-
rium. We thus choose a Lyapunov function V = aL+ bH + cT + dD, where the Lyapunov
coefficients are such that a, b, c, d > 0. The corresponding derivative of the Lyapunov
function is given by
V˙ = aL˙+ bH˙ + cT˙ + dD˙,
= aΛS + (bσ − aQ1 + dα2)L+ (aγ2 − bQ2 + cρ+ dα3)H
+ (bγ3 − cQ3)T + (aα1S −Q4d)D.
(4.22)
We linearise the Lyapunov derivative (4.22) at the drug free equilibrium. We note that
near the DFE, S ≤ π
µ
and therefore, S
N
≤ 1. Using this relation, we obtain
V˙ ≤ (aβ + bσ − aQ1 + dα2)L+ (aβη1 + aγ2 − bQ2 + cρ+ dα3)H
+ (aβη2 + bγ3 − cQ3)T +
(
aα1
π
µ
−Q4d
)
D.
(4.23)
We choose the coefficients a, b, c, d such that the coefficients of H ,T and D are zero. We
thus obtain
a = µQ2Q3Q4(1− Φ1), b = µQ3Q4(βη1 + γ2) + ρµQ4βη2 + α1πα3µQ3,
c =
µQ2Q3Q4(1− Φ1)βη2 + bγ3
Q3
, d = α1πµQ2Q3(1− Φ1).
We now substitute the coefficients in (4.23) to obtain
V˙ ≤ µQ1Q2Q3Q4(1− Φ1 − Φ2) [R0UD − 1]L.
Clearly, V˙ ≤ 0 whenever R0UD ≤ 1 with equality only when R0UD = 1 or L = 0. Thus,
according to the LaSalle Invariance principle [15], the DFE is globally asymptotically stable.
This completes the proof.
4.4.2 Local Stability of the Drug Persistent Equilibrium
We use the center manifold theory described in [16] to determine the local stability of the
endemic steady state. Let us consider the system of equations (4.1) with the bifurcation
parameter φ such that
dx
dt
= f(x, φ), f : R5 × R→ R and f ∈ C2(R5 × R). (4.24)
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Clearly if 0 is the steady state of system (4.1), then f(0, φ) = 0 for all φ. Let the lineari-
sation matrix, A
A = Dxf(0, 0), (4.25)
have a left eigenvector denoted by y and a right eigenvector denoted by v. Then the local
dynamics of the model around 0 is totally governed by a and b [16, 71], where
a =
∑
k,i,j=1
ykvivj
∂2fk
∂xi∂xj
(0, 0), (4.26)
b =
∑
k,i,j=1
ykvi
∂2fk
∂xi∂φ
(0, 0). (4.27)
Let us now define the terms (S, L,H, T,D) as (x1, x2, x3, x4, x5). Then the system (4.1)
can be rewritten as
x˙1 := f1 = π + γ1x2 − β
(
x2 + η1x3 + η2x4∑4
i=1 xi
)
x1 − α1x1x5 − µx1,
x˙2 := f2 = β
(
x2 + η1x3 + η2x4∑4
i=1 xi
)
x1 + γ2x3 + α1x1x5 −Q1x2,
x˙3 := f3 = σx2 + γ3x4 −Q2x3,
x˙4 := f4 = ρx3 −Q3x4,
x˙5 := f5 = α2x2 + α3x3 −Q4x5.
(4.28)
We evaluate the bifurcation parameter φ by equating R0UD to one to obtain
φ = β∗ =
µQ1Q2Q3Q4[1− (Φ1 + Φ2)]− α1πQ3(α2Q2(1− Φ1) + σα3)
µ[Q2Q3Q4(1− Φ1) + ησQ3 + η2ρσ]
.
We linearise the system of equations (4.1) at the drug free equilibrium and with the bifur-
cation parameter φ to obtain
J =


−µ γ1 − β
∗ −β∗η1 −β
∗η2 −α1
π
µ
0 β∗ −Q1 β
∗η1 + γ2 β
∗η2 α1
π
µ
0 σ −Q2 γ3 0
0 0 ρ −Q3 0
0 α2 α3 0 −Q4


. (4.29)
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The matrix (4.29) has a left eigenvector given by y = (y1, y2, y3, y4, y5)T , whose components
are
y1 = 0,
y2 = µQ2Q3Q4(1− Φ1),
y3 = (β
∗η1 + γ2)µ
2Q3Q
2
4 + µα1α3πQ3Q4 + β
∗η2ρµQ4,
y4 = β
∗η2µQ2Q4(1− Φ1) +
γ3
Q3
y3,
y5 = α1πQ2Q3(1− Φ1).
The right eigenvector associated with the zero eigenvalue of (4.29) is v = (v1, v2, v3, v4, v5)T ,
where
v1 = Q1Q2Q3Q4(1− Φ1 − Φ2)[R
∗
0UD − Rc] with Rc =
γ1(1− Φ1)
Q1(1− Φ1 − Φ2)
,
v2 = µQ2Q3Q4(1− Φ1), v3 = Q3Q4σµ,
v4 = σµρQ4, v5 = α2µQ2Q3(1− Φ1) + α3µQ3σ,
where
R∗0UD =
β∗ [Q2Q3(1− Φ1) +Q3η1σ + ρη2σ)
Q1Q2Q3 (1− (Φ1 + Φ2)]
+
α1π [α2Q2(1− Φ1) + σα3]
µQ1Q2Q4 (1− (Φ1 + Φ2))
,
and Rc < R
∗
0UD.
We now evaluate the non-zero second order mixed derivatives of with respect to the vari-
ables. We thus have the following
∂2f1
∂x2∂x3
=
∂2f1
∂x3∂x2
= β∗
(1 + η1)µ
π
,
∂2f1
∂x2∂x4
=
∂2f1
∂x4∂x2
= β∗
(1 + η2)µ
π
,
∂2f1
∂x3∂x4
=
∂2f1
∂x4∂x3
= β∗
(η1 + η2)µ
π
,
∂2f1
∂x1∂x5
=
∂2f1
∂x5∂x1
= −α1,
∂2f2
∂x2∂x3
=
∂2f2
∂x3∂x2
= −β∗
(1 + η1)µ
π
,
∂2f2
∂x2∂x4
=
∂2f2
∂x4∂x2
= −β∗
(1 + η2)µ
π
,
∂2f2
∂x3∂x4
=
∂2f2
∂x4∂x3
= −β∗
(η1 + η2)µ
π
,
∂2f2
∂x1∂x5
=
∂2f2
∂x5∂x1
= α1.
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The non-zero partial derivatives used in calculating b are
∂2f1
∂x2∂φ
= −1,
∂2f2
∂x2∂φ
= 1,
∂2f1
∂x3∂φ
= −η1,
∂2f2
∂x3∂φ
= η1,
∂2f1
∂x4∂φ
= −η2,
∂2f2
∂x4∂φ
= η2.
We now substitute the expressions into (4.26) and (4.27) to obtain
a = −2µQ2Q3Q4(1− Φ1)
[
µβ∗
π
(v2v3(1 + η1) + v2v4(1 + η2) + v3v4(η1 + η2)) + v1v5α1
]
,
b = µQ2Q3Q4(1− Φ1) [µQ2Q3Q4(1− Φ1) + η1µσQ3 + η2µσQ2] .
We observe that a < 0 and b > 0. We thus have the following result.
Theorem 4.4.3. The drug persistent steady state is locally asymptotically stable when
R0UD > 1 and R0UD close to 1.
4.5 Numerical Results
In this section, we illustrate the theoretical results of the model by numerically integrating
the model system (4.1). The demographic parameters µ, δ1 and δ2 which regulate the
dynamics of the population of the susceptible population, light users and heavy users
respectively, are specific to sub-Saharan Africa. The nominal values of the parameter
values used in the model are indicated in Table. 4.5.
The simulations in this chapter are synonymous with those in Chapter 3. In this chapter
we concentrate on the influence of drug lords.
We vary the initial population of light drug users and simulate the prevalence of drug
user. In the long term Figure 4.2, the prevalence in the evolving population converges
to a similar point. To investigate the relationship between law enforcement and contact
between drug lords and potential initiates, we vary the contact rate α1 between drug lords
and drug users from 0.04 to 0.3 and present results in Figure 4.5. The prevalence rate is
observed to increase from undetectable levels (approximately 0%) to 12.7 (Figure 4.4(a)).
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Parameter nominal value Range Source
π 0.04 0.028-0.080 [71]
η1 0.8 (0-1) Estimated
η2 0.6 (0,1) Estimated
β 0.105 [0.10-0.21] [71]
σ 0.56 0.40-0.70 Estimated
ρ 0.223 0.17-0.30 Estimated
k 0.20 0.15-0.50 Estimated
µ 0.02 0.019-0.021 [1]
γ1 0.20 0.10-0.60 Estimated
γ2 0.4 0.2-0.5 Estimated
γ3 0.25 0.2-0.5 Estimated
α1 0.4 0-1 Estimated
α2 0.04 0-1 Estimated
α3 0.08 0-1 Estimated
r 0.05 0-1 Estimated
Table 4.2. Parameter values used in the extended model with drug lords
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Figure 4.2. Prevalence of substance abuse with different initial population of light drug
users
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Figure 4.3. The impact of law enforcement on the prevalence of substance abuse
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(a) Prevalence of substance abuse without law en-
forcement, (r = 0).
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(b) Prevalence of substance abuse with law enforce-
ment (r = 0.08).
Figure 4.4. Shows that, given the same initiation potential by drug lords, effective policing
and law enforcement, will always keep the prevalence of drug abuse lower than it would
have been without law enforcement.
When compared with the case in absence of law enforcement but for similar contact rates
between drug lords and drug users, the prevalence of substance abuse is observed to increase
from 0.5% to 60.0% (Figure 4.4(b)). In the same way, we observe from Figures. 4.3 and 4.5
that, law enforcement reduces prevalence, and from Figure 4.5 in particular, increasing law
enforcement by 8% can reduce prevalence by up to 50%. The reason for such a decrease
is due to the fact that; when the population of drug lords reduces, so does the supply of
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Figure 4.5. Contribution of law enforcement in drug epidemics. The green shading indi-
cates the prevalence can be reduced by up to 50% when law enforcement is increased by
approximately 8%. For the interpretation of this figure with regard to colour, the reader
is referred to the electronic version.
substances to potential users and the probability that a susceptible individual will meet a
drug lord or acquire an addictive substance consequently reduces.
4.6 Summary
In this chapter, we presented a compartmental model for general substance abuse showing
the influence of drug lords on the prevalence of substance abuse. Qualitative evaluation
of the effectiveness of law enforcement as a means of intervention on general substance
abuse epidemic was evaluated. The quantity of law enforcement directed towards curbing
problematic drug usage, is not easy to measure. However, we arbitrarily quantified it
using numerical values. The resulting plots produced on law enforcement are out of the
motivation based on scenario analysis. In this process, we analysed the possible outcomes
(trend of drug use prevalence) by considering alternative input values of law enforcement.
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The results indicate that stepping up law enforcement reduces the prevalence of substance
abuse. The interpretation of this being that; in the ideal case, if drugs were completely
unavailable, there would be no drug addiction, see also [36]. Reducing the number of
drug lords reduces the probability of a susceptible individual being initiated into substance
abuse by a drug lord.
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Impact of Substance Abuse on the
Prevalence of HIV
5.1 Introduction
Most abused substances are not only psychoactive and influencing mind swing of the users,
they also put the drug users at a risk of contracting infections such as Hepatitis B, Hep-
atitis C, HIV and other sexually transmitted infections. Heavy drug usage and alcohol
heightens sexual urge in men, increasing the probability of the user socializing in areas
(such Shebeens) where they can easily find a sexual partner, as well as having multiple
partners. In the event of sexual contact, drug users are highly likely not to use condoms,
or if they happen to use one, the probability of improper usage is high. In the case of
injectable drug use, there is direct administration of potentially contaminated body fluids
from one individual to another through needle sharing. In the longitudinal assessment of
the effect of drug and alcohol abuse on HIV-1 treatment [55], it was noted that, switching
from non use to substance use for HIV infected individuals is associated with worsening
antiretroviral therapy (ART) use and adherence, less frequent HIV-1 RNA suppressors
and blunted CD4 increases, compared to remaining free from substance use. Alternatively,
switching from alcohol and drug use to non use, is associated with general improved health.
In HIV seropositive individuals, the immune suppression and immunomodulation further
compromise their immune system increasing susceptibility to opportunistic infections and
consequently faster progression to AIDS. Therefore, abuse of alcohol and drugs is corre-
76
Stellenbosch University http://scholar.sun.ac.za
Chapter 5. 77
lated with the risk of acquiring HIV and consequently, the increase in viral load in the
community. In the same way, suppression of the immune system is associated with low
CD4 count hence leading to early start of ART for infected individuals.
A number of studies on mathematical modelling involving co-infection dynamics have been
done. For example HIV and tuberculosis [4, 79, 85], HIV and Malaria [63] among others.
Some studies have also been done with respect to co-dynamics between substance abuse
and other infection but little work has been done regarding mathematical modelling. We
cite some of the work known to us so far; for example Crack-Cocaine and HIV [13], alcohol
and gonorrhea [66], heavy alcohol drinking and HIV [31]. In this chapter, we construct a
useful mathematical model for the dynamics of substance abuse and HIV with the interest
of finding out the effect of sexual habits (increased sexual activity resulting from high
substance consumption) and information dissemination on the prevalence of HIV.
5.2 The Model
To model the impact of substance abuse on the dynamics of HIV, we extend the conceptual
compartmental model presented in Chapter 3. In this model, we divide the general pop-
ulation involved in the drug use cycle into two main groups (i.e HIV negative individuals
and HIV positive individuals) each with four states (susceptible, light users, heavy users
and users under rehabilitation). The total population N1 evolving over time as divided
into non-intersecting subgroups depending on theirs substance abuse and HIV status and
is given by
N1(t) = S1(t) + S2(t) + L1(t) + L2(t) +H1(t) +H2(t) + T1(t) + T2(t)
The notation of the eight compartments is indicated in the Table 5.1. This model is
based on the assumption that; (i) there is homogeneous mixing between individuals, (ii)
all individuals (S1, L1, H1 and T1) are susceptible to HIV and all non drug users (S1 and
S2) are susceptible to initiation into drug use. The susceptible population is generated
by a constant recruitment of individuals into the population. Susceptible individuals S1
can be initiated into substance abuse following effective interaction with substance users
as indicated in Chapter 3. In this chapter however, we account for additional initiations
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βL2S1/N1, βη1φ1H2S1/N1 and βη2φ2T2S1/N1 due to interaction with HIV-infected drug
users L2, H2 and T2 respectively. The initiation function for substance abuse is therefore
given by
Γ = β (L1 + L2 + η1(H1 + φ1H2) + η2(T1 + φ2T2)) /N1 (5.1)
The parameters η1 and η2 measure the relative initiation rates of substance users in classes
H1, H2, T1 and T2 compared to L1 and L2. We assume that parameters η1 and η2 take
up value 0 < η1, η2 < 1 as indicated in Chapter 3. The parameters φ1 and φ2 with
0 < φ1, φ2 < 1 account for further reduction in initiation ability by individuals in H2
and T2 classes as a result substance abuse symptomatic manifestations and rehabilitation
respectively. We note that in absence of HIV infection in the population of drug users, the
initiation function (5.1) reduces to the function (3.1) used in Chapter 3.
In the model, we use the non-linear transmission function f(P ) = de(−λP ) similar to the
transmission function used in the Tuberculosis/ HIV co-infection model [4]. The product
of the reduced transmission rate of HIV (f(P ) = de−λP ) and the prevalence P give the
effective transmission rate for HIV (g = f(P )P = de(−λP )P ), where parameter d depends
on the sexual habits of drug users and the local cofactors for the transmission of HIV such
as other sexually transmitted infections, and λ the “the speed at which information on HIV
diffuses”. It has been clearly noted in [13] that increased awareness of the HIV pandemic
influences changes in behaviour for example, injecting cocaine users resorting to cocaine
smoking consequently reducing the HIV incidence rate. Although the whole population is
susceptible to HIV, we limit our model discussion to the population susceptible to using
drugs. HIV-negative individuals (in compartments S1, L1, H1, T1) can contract HIV
through effective contact with HIV-positive individuals (S2, L2, H2, T2) at an effective
transmission rate g. We use this effective transmission rate for both drug users and non-
drug users for mathematical tractability. However, we acknowledge the fact that the two
groups may not entirely be at the same risk of becoming HIV-positive. Natural mortality
rates occur in all compartments at a rate µ1 for HIV-negative population and µ2 for the
HIV positive population. Similar to H1 and T1, individuals in the classes H2 and T2 suffer
additional removal related to drug use, incarceration and aggravated mortality at constant
rates δ2 and d2 respectively. The description of parameters of the extended model is given
it Table 5.2.
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Parameter Description
S1 Number of HIV− people not using drugs
S2 Number of HIV+ people not using drugs
L1 Number of HIV− light drug users
L2 Number of HIV+ light drug users
H1 Number of HIV− heavy drug users
H2 Number of HIV+ heavy drug users
T1 Number of HIV− drug users on treatment
T2 Number of HIV+ drug users on treatment for drugs
N1 Total population N1 = S1 + S2 + L1 + L2 +H1 +H2 + T1 + T2
P Prevalence of HIV P = (S2 + L2 +H2 + T2)/N1
g Effective transmission rate of HIV g = f(P )P
Table 5.1. The eight compartments of the model
Figure 5.1. Shows the coexistence of substance abuse and HIV
The model equations are given as follows
dS1
dt
= π + γ1L1 − ΓS1 − µ1S1 − f(P )PS1, (5.2)
dL1
dt
= ΓS1 + γ2H1 − (µ1 + σ1 + γ1)L1 − f(P )PL1, (5.3)
dH1
dt
= σ1L1 + γ3T1 − (µ1 + δ1 + γ2 + ρ1)H1 − f(P )PH1, (5.4)
dT1
dt
= ρ1H1 − (µ1 + d1 + γ3 + k1)T1 − f(P )PT1. (5.5)
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for HIV− people, and
dS2
dt
= f(P )PS1 + ξ1L2 − ΓS2 − µ2S2, (5.6)
dL2
dt
= ΓS2 + f(P )PL1 + ξ2H2 − (µ2 + ξ1 + σ2)L2, (5.7)
dH2
dt
= f(P )PH1 + σ2L2 + ξ3T2 − (µ2 + δ2 + ξ2 + ρ2)H2, (5.8)
dT2
dt
= f(P )PT1 + ρ2H2 − (µ2 + d2 + ξ2 + k2)T2, (5.9)
for HIV+ people with initial conditions
S1(0) = S10 > 0, L1(0) = L10 > 0, H1(0) = H10 > 0, T1(0) = T10 > 0,
S2(0) = S20 > 0, L2(0) = L20 > 0, H2(0) = H20 > 0, T2(0) = T20 > 0. (5.10)
Table 5.2. Description of parameters used in the model.
Symbol Description
β The effective contact rate between drugs users and the susceptible population
η1 The relative ability to initiate new drug users by heavy users
η2 The relative ability to initiate new drug users by users in rehabilitation
φ1, φ2 Further reduction in Initiation ability by H2 and T2 respectively
π Recruitment rate into the susceptible population
µ1, µ2 Natural mortality rate of the HIV− and HIV+ population respectively
σ1, σ2 The mean rate at which light users escalate to heavy drug use
γ1, ξ1 The mean rate at which light users quit and become susceptible again
γ2, ξ2 The mean rate at which heavy drug users move back into light drug use
ρ1, ρ2 The mean rate at which heavy drug users are recruited into rehabilitation
γ3, ξ3 The mean rate at which those under rehabilitation relapse into heavy drug use
δ1, δ2 Removal rate related to drug use for heavy drug users
d1, d2 Removal rate related to drug use for users under rehabilitation
k1, k2 The mean rate at which users in rehabilitation permanently quit
5.3 Positivity of Solutions
The system (5.2)-(5.9) can be analysed in the domain Ω3 ⊂ R
8
+.
Theorem 5.3.1. The solutions of the system of equations (5.2)-(5.9) with initial conditions
(5.10) satisfy S1(t) > 0, L1(t) > 0, H1(t) > 0, T1(t) > 0, S2(t) > 0,L2(t) > 0, H2(t) > 0,
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T2(t) > 0 for all t > 0. The region Ω3 ⊂ R
8
+ is attracting with respect to (5.2)-(5.9) and
positively invariant.
Proof. Consider the equation
dS1
dt
= π + γ1L1 − ΓS1 − µ1S1 − f(P )PS1.
clearly
dS1
dt
≥ π − (Γ + µ1 + f(P )P )S1.
Using the corresponding integrating factor, we have the following results
d
dt
[
S1(t)exp
{
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
}]
≥ πexp {µ1t+∫ t
0
(Γ(τ) + f(P (τ))P (τ))dt
}
.
Integrating the above inequality results in
S1(t)exp
{
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
}
− S1(0) ≥∫ t
0
πexp
{
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
}
dt. (5.11)
Clearly
S1(t) ≥ S10exp
{
−
[
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
]}
+
exp
[
−
(
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
)]
×[∫ t
0
πexp
(
µ1t+
∫ t
0
(Γ(τ) + f(P (τ))P (τ))dτ
)
dt
]
> 0.
Similarly, it can be shown that L1, H1, T1, S2, L2, H2, and T2 > 0, for all t > 0. We can
therefore conclude that the solutions of (5.2)-(5.9) with initial conditions (5.10) remain
positive for all t > 0. This completes the proof.
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5.4 Model Analysis
Note that the model presented in this chapter is an extension of the model of substance
abuse presented in Chapter 3. Therefore, since the analysis involving only substance abuse
has been done in Chapter 3, in this chapter we focus on the analyses involving HIV and
co-existence of the two epidemics.
5.4.1 HIV only Equilibrium
We begin by considering the population with no substance abuse, but with HIV infection
only. For the analysis in this subsection, we follow the procedure outlined in [4]
Proposition 5.4.1. The model system (5.2)-(5.9) has a drug free equilibrium given by
E
0
HIV
= (Sˆ1, 0, 0, 0, Sˆ2, 0, 0, 0).
When the population involves only HIV persons, the system of equations (5.2)-(5.9) reduces
to
dS1
dt
= π − µ1S1 − f(P )PS1,
dS2
dt
= f(P )PS1 − µ2S2, (5.12)
where P , the prevalence rate of HIV is given by
P =
S2
S1 + S2
.
We now evaluate the reproduction number of the RHIV0 by linearising the second equation
of (5.12) near the disease free-steady state; where S2 = 0
dS2
dt
≃ f(0)S2 − µ2S2, (5.13)
=
(
f(0)
µ2
− 1
)
µ2S2. (5.14)
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The threshold number for HIV is given as RHIV0 =
f(0)
µ2
. We note that
dS2
dt

> 0 if R
HIV
0 > 1,
≤ 0 if RHIV0 ≤ 1.
The system (5.12) has an equilibrium point Eˆ0 given by Eˆ0 =
(
Sˆ1, Sˆ2
)
. At this equilibrium
point the prevalence Pˆ will be given by
Pˆ =
Sˆ2
Sˆ1 + Sˆ2
. (5.15)
Note that at the equilibrium point Eˆ0 the equations (5.12) satisfy
π = µ1Sˆ1 + f(Pˆ )Pˆ Sˆ1, (5.16)
0 = f(Pˆ )Pˆ Sˆ1 − µ2Sˆ2. (5.17)
Using equations (5.17) and (5.15) we evaluate the steady state such that
Sˆ1 =
π(1− Pˆ )
µ1(1− Pˆ ) + µ2Pˆ
, Sˆ2 =
πPˆ
µ1(1− Pˆ ) + µ2Pˆ
. (5.18)
If we combine the equations (5.17) and (5.15), we obtain
f(Pˆ )(1− Pˆ ) = µ2. (5.19)
We note that when Pˆ = 0, then f(Pˆ ) = d and when Pˆ = 1, then the left hand side of
(5.19) is zero. Thus, the left side of (5.19) is a decreasing function of Pˆ in the interval
(0, 1), see also [4].
5.5 The Reproduction Number for the Coinfection Model
We linearise the system (5.6)-(5.9) near the steady state when only substance abuse is
prevalent. We also let
s∗1 =
S∗1
N∗
, l∗1 =
L∗1
N∗
, h∗1 =
H∗1
N∗
, t∗1 =
T ∗1
N∗
to obtain
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dS2
dt
≃ f(0)s∗1(S2 + L2 +H2 + T2) + ξ1L2 − ΛS2 − µ2S2,
dL2
dt
≃ f(0)l∗1(S2 + L2 +H2 + T2) + ΛS2 + ξ2H2 −Θ1L2,
dH2
dt
≃ f(0)h∗1(S2 + L2 +H2 + T2) + σ2L2 + ξ3T2 −Θ2H2,
dT2
dt
≃ f(0)t∗1(S2 + L2 +H2 + T2) + ρ2H2 −Θ3T2.
We then evaluate the threshold number rHIV0 when HIV is introduced in the population
with substance abuse at the steady state. We use the next generation matrix method [100]
where
Fi =


f(0)s∗1(S2 + L2 +H2 + T2
f(0)l∗1(S2 + L2 +H2 + T2)
f(0)h∗1(S2 + L2 +H2 + T2)
f(0)t∗1(S2 + L2 +H2 + T2)

 , and F = f(0)


s∗1 s
∗
1 s
∗
1 s
∗
1
l∗1 l
∗
1 l
∗
1 l
∗
1
h∗1 h
∗
1 h
∗
1 h
∗
1
t∗1 t
∗
1 t
∗
1 t
∗
1

 .
νi =


−ξ1L2 + ΛS2 + µ2S2
−ΛS2 − ξ2H2 +Θ1L2
−σ2L2 − ξ3T2 +Θ2H2
−ρ2H2 +Θ3T2

 , and V =


(Λ∗ + µ2) −ξ1 0 0
−Λ∗ Θ1 −ξ2 0
0 −σ2 Θ2 −ξ3
0 0 −ρ2 Θ3

 .
The reproduction number rHIV0 is given by
rHIV0 = ρ(FV
−1) = f(0)(s∗1τS2 + l
∗
1τL2 + h
∗
1τH2 + t
∗
1τT2),
such that
τS2 =
(1− ε1)(Λ
∗Θ2Θ3 +Θ1Θ2Θ3) + σ2ρ2Λ
∗ + σ2Θ3(Λ
∗ − ξ2)
(µ2 + Λ∗)Θ1Θ2Θ3[1− ε1 − ε2 − ε3(1− ε1)]
,
τL2 =
ξ1Θ2Θ3(1− ε1) + (µ2 + Λ
∗)[σ2(1 + ρ2) + Θ2Θ3(1− ε1)]
(µ2 + Λ∗)Θ1Θ2Θ3[1− ε1 − ε2 − ε3(1− ε1)]
,
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τH2 =
ξ1(Λ
∗(ρ2 −Θ2) + ξ2Θ3) + (µ2 + Λ
∗)(ξ2Θ2 + ρ2Θ1 +Θ1Θ3)
(µ2 + Λ∗)Θ1Θ2Θ3[1− ε1 − ε2 − ε3(1− ε1)]
,
τT2 =
(ξ2ξ3 − ξ3Λ
∗ + ξ1Θ2) + (µ2 + Λ
∗)(ξ2ξ3 − σ2ξ2 + ξ3Θ1 +Θ1Θ2)
(µ2 + Λ∗)Θ1Θ2Θ3[1− ε1 − ε2 − ε3(1− ε1)]
,
where ε1 =
ξ3ρ2
Θ2Θ3
, ε2 =
σ2ξ2
Θ1Θ3
, ε3 =
ξ3Λ∗
Θ1(µ2+Λ∗)
. The term ε1 shows the probability of moving
from one of L2 and H2 to the other and back again. The expressions τS2 , τL2 , τH2 and τT2
in the linearised model can be interpreted as life expectancies. For example τS2 is the life
expectancy of an individual from the moment that person enters state S2. See also [4]. The
terms τS2 , τL2 , τH2 and τT2 are strictly less than 1/µ2. Therefore, the expected number of
secondary HIV-cases initiated by an average “HIV positive” individual in a population with
substance abuse epidemic is less than in the population with no substance abuse. This is
because problematic substance abuse reduces the average time an individual spends in a
particular compartment drug related removal.
Similarly, the endemic steady state of HIV can be invaded by substance abuse. We now
linearise the equations (5.3), (5.4), (5.5), (5.7), (5.8) and (5.9) near (Sˆ1, 0, 0, 0, Sˆ2, 0, 0, 0)
and set
Nˆ = Sˆ1 + Sˆ2, sˆ1 =
Sˆ1
Nˆ
, sˆ2 =
Sˆ2
Nˆ
= Pˆ .
Then we obtain
dL1
dt
≃ β(L1 + L2 + η1(H1 + φ1H2) + η2(T1 + φ2T2))sˆ1 + γ2H1 −Q1L1 − f(Pˆ )PˆL1,
dH1
dt
≃ σ1L1 + ξ1T1 −Q2H1 − f(Pˆ )PˆH1,
dT1
dt
≃ ρ1H1 −Q3T1 − f(Pˆ )Pˆ T1,
dL2
dt
≃ β(L1 + L2 + η1(H1 + φ1H2) + η2(T1 + φ2T2))sˆ2 + f(Pˆ )PˆL1 + ξ2H2 −Θ1L2,
dH2
dt
≃ f(Pˆ )PˆH1 + σ2L1 + ξ3T2 −Θ2H2,
dT2
dt
≃ f(Pˆ )Pˆ T2 + ρ2H2 −Θ3T2.
Then the reproduction number rsub0 for substance abuse when introduced in the population
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in which HIV is endemic is the spectral radius of the matrix NM−1, for
N =


sˆ1 η1sˆ1 η2sˆ1 sˆ1 η1φ1sˆ1 η2φ2sˆ1
0 0 0 0 0 0
0 0 0 0 0 0
sˆ2 η2sˆ2 η1φ1sˆ2 sˆ2 η2sˆ2 η2φ2sˆ2
0 0 0 0 0 0
0 0 0 0 0 0


,
M =


Q1 −γ2 0 0 0 0
−σ1 Q2 −ξ1 0 0 0
0 −ρ Q3 0 0 0
−G 0 0 Θ1 −ξ2 0
0 −G 0 −σ2 Θ2 −ξ3
0 0 −G 0 −ρ2 Θ3


,
where Q1 = Q1 + f(Pˆ )Pˆ , Q2 = Q2 + f(Pˆ )Pˆ , Q3 = Q3 + f(Pˆ )Pˆ and G = f(Pˆ )Pˆ . The
resulting characteristic polynomial yields two distinct eigenvalues, of which the maximum
is the expression of rsub0 . Whether the magnitude of r
sub
0 is greater or smaller than R0 in
Chapter 3 depends on the parameter values chosen. The coinfection model is complicated
to deduce reasonable analytical results, thus we resort to numerical simulations.
5.6 Numerical Simulation
We carry out numerical simulation to determine the behaviour of population of drug users
and the trend of HIV among the drug using populations. We estimate some of the pa-
rameters to be used in the numerical simulations and detail them in Table 5.4. The
demographic parameters µ1 and µ2 are specific to the sub- Saharan region. The param-
eter µ2 = 0.1per year correspond to the life expectancy of 10 year for the HIV infected
individuals [4] and the references therein. However, this value can be higher or smaller
(8− 20 years) depending on the nutrition and life style of these individuals.
Parameters d, λ and t0; To estimate these HIV related parameters we follow the method
used in [4]. This is feasible because similar data is used to estimate these parameter.
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These parameters are necessary and usually sufficient to fit any set of increasing numbers
resembling the logistic curve [4]. We use data for prevalence of HIV infection in a peri-
urban community in the Western Cape province of South Africa 1996 − 2004, to fit the
model to data and derive the specific parameters. The HIV prevalence data obtain from
[4, 52] is indicated in Table 5.3.
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
Pop’n Size 5518 6429 7339 8250 9161 10,071 10,982 11,892 12,803
HIV Prev(%) 6.3 8.9 11.6 14.2 16.5 18.4 19.9 21.1 21.9
Est. HIV + people 348 572 851 1172 1512 1853 2185 2509 2804
Table 5.3. HIV prevalence in a peri-urban community in the Western Cape.
We sum the first four equations (5.2)-(5.5) for HIV− people and the four equations (5.6)-
(5.9) for HIV+ people. Setting X1 = S1 + L1 +H1 + T1 and X2 = S2 + L2 +H2 + T2 and
taking the prevalence to be X = X2
X1+X2
, we obtain
dX1
dt
= π − µ1X1 − f(P )PX1 − δ1H1 − (d1 + k1)T1, (5.20)
dX2
dt
= f(P )PX1 − µ2X2 − δ2H2 − (d2 + k2)T2. (5.21)
To estimate the parameters d, λ and t0, we assume that the terms involving H1, T1, H2
and T2 form a very small proportion of the drug using population and therefore ignore
them. The resulting system is in terms of X1 and X2. If we take the base year for the for
the onset of HIV to be t0 = 1980, then we have; X1(t0) =
π
µ1
and X2(t0) = 1.
The parameter values entered in the Table 5.4 are estimated values per year.
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Parameter Range Value Source Parameter Range Value Source
β 0.3 fitted γ3 0.3-0.5 0.45 fitted
η1 0-1 0.6 fitted ξ1 0.1-0.4 0.18 fitted
η2 0-1 0.4 fitted ξ2 0.24 fitted
φ1 0-1 0.3 fitted ξ3 0.4 fitted
φ2 0-1 0.25 fitted ρ1 0.17-0.3 0.23 fitted
π 400 fitted ρ2 0.17-0.4 0.3 fitted
µ1 0.02 [1] δ1 0.0028 fitted
µ2 (0.05-0.125) 0.1 [4] δ2 0.0028 fitted
σ1 0.2-0.6 0.3 fitted d1 0.0014 fitted
σ2 0.2-0.6 0.5 fitted d2 0.0038 fitted
γ1 0.3-0.5 0.25 fitted k1 0.1-0.5 0.45 fitted
γ2 0.3-0.5 0.28 fitted k2 0.2-0.5 0.3 fitted
d 0.48-0.50 0.49 fitted λ 5.3-5.8 5.6 fitted
Table 5.4. Parameter values used in model simulations
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Figure 5.2. A graphical representation of the HIV positive population from the model
(5.2)-(5.9) fitted to data for HIV positive individuals in Table 5.3
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Figure 5.3. Variation of the population of HIV positive non drug users and the population
of HIV positive drug users.
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Figure 5.4. Prevalence of substance abuse among HIV infected individuals.
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Figure 5.5. Impact of the speed at which information about HIV spreads on the prevalence
of HIV among drug users.
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Figure 5.6. Effect of sexual hyperactivity and other local cofactors on the prevalence of
HIV.
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5.7 Summary
The simulation results in Figure 5.2, show the mathematical model fitted to the HIV
prevalence data in Table 5.3 from a peri-urban community in the Western Cape. The
parameter values used for the model simulation are as indicated in Table 5.4. Information
dissemination is an important component in the control of epidemics associated with hu-
man behaviour. We observe that increasing the spread of information about HIV, Figure
5.5, reduces the prevalence of HIV among drug users. This is mainly due to change in
behaviour, for example, injecting drug users resorting to smoking drugs in the case of HIV.
Our simulations show that the unprecedented increase in both drug use and spread of HIV
occurred in the mid 1990′s. Our results suggest that most individuals who start using
substances end up becoming drug dependent, and if no control measures are taken, in the
long run every four of ten drug dependent HIV positive individuals will require treatmen-
t/rehabilitation related to substance abuse. This consequently has worse implications on
the efficacy of antiretroviral therapy and adherence to it, CD4 cell count and immuno mod-
ulation among drug dependent HIV seropositive individuals. Heavy alcohol consumption
and drug addiction are associated with sexual hyperactivity and increased sexual contact
increases the risk of contracting HIV. Our results in Figure 5.6 suggest that, there is faster
spread of the HIV epidemic and high prevalence with increased sexual contact.
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Conclusion and Discussion
In this thesis, we studied the general substances abused, highlighting those abused heavily,
moderately and to a low extent. With specific reference to heavily abused drugs, we
highlighted the modes of administration of such drugs, the time at which peak plasma
concentrations are reached and the general health effects associated with each of the drugs
considered. In addition, we considered the factors that account for the spread of drug
epidemic as well as factors responsible for its reduction.
In this study we presented two models on substance abuse and one model on the relation
between substance abuse and HIV/AIDS. The first model presented in Chapter 3, describes
the dynamics of substance abuse based on the assumption that drug users behave as
diseased individuals and that a susceptible individual meets only a fraction drug users.
The model incorporates key aspects such as recruitment into rehabilitation, relapse at
a constant rate, amelioration and quitting of light drug users in addition to interaction
(contact) between drug users and the susceptible population. This model was extended in
Chapter 4 to incorporate a compartment of drug lords as the main drug supply chain. The
main interest here was to investigate the contribution of drug lords in drug epidemics and
the impact of law enforcement on the prevalence of substance abuse. Our results indicate
that; the presence of drug lords increases the prevalence of substance abuse. On the other
hand, law enforcement reduces the population of drug suppliers and consequently the
prevalence of substance abuse. In Chapter 5, a model incorporating the possibility of drug
users contacting HIV was presented. This transition from HIV-negative to HIV-positive
state is associated with behavioural change, drug use patterns, sexual life style and response
92
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to information dissemination regarding HIV/AIDS. Qualitative and numerical analyses of
all the above mentioned models was done.
Mathematical analysis of the model with amelioration, Chapter 3, indicates that there
exists a drug free steady state which is globally stable whenever R0 < 1 and a unique drug
persistent steady state which is globally stable when R0 > 1. The epidemiological inter-
pretation of this being that, substance abuse can be eliminated if the reproduction number
is reduced to a value below unity. The importance of model parameter to the prevalence
and spread of drug epidemics was investigated using the normalised forward sensitivity
indices with respect to the reproduction number. This sensitivity analysis together with
the numerical simulations consistently show that prevalence of substance abuse increases
with increase in the influence (contact) of drug users on the susceptible population, re-
initiation (relapse or reversion) into drug use and amelioration in the absence of quitting
for light users. On the other hand, prevalence of substance abuse reduces with increase
in recruitment into rehabilitation, and with amelioration in presence of quitting for light
users. Analysis of the model involving drug lords indicates existence of a globally asymp-
totically stable steady state whenever R0UD < 1 and a possibility of two endemic equilibria
when R0UD > 1. We note that, at all times R0 < R0UD. Therefore, the contribution of drug
lords in drug epidemics is significant and can not be overlooked. The numerical results
indicate that effective interaction between drug lords and potential drug users increases the
prevalence of substance abuse whereas increased law enforcement reduces the prevalence
of substance abuse.
In order to understand the potential impact of substance abuse on the prevalence of
HIV/AIDS, we formulated a model with maximum transmissitivity and dissemination of
information on HIV/AIDS among drug users. Our analysis suggests that in absence of sub-
stance abuse, HIV can be eliminated if RHIV0 is reduced below unity. Otherwise, it remains
prevalent. We observed that, increasing the spread of HIV/AIDS related information in
the population directly reduces the prevalence of the epidemic.
In this research, we were able to understand the drugs abused, and the key factors that
influence the dynamics of substance abuse. We were also able to identify the key target pa-
rameters for controlling drug epidemics and consequently HIV/AIDS. Our recommendation
for further research on this topic are as follows:
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1. The fact that different age groups have different drug using patterns, it is important
to structure the population into different age groups. This may help researchers and
policy makers to;
• assess the demographic impact of drugs with significant morbidity and mortality.
• estimate parameters related to drug use patterns from age-specific data.
• design control and intervention programs to protect vulnerable age groups.
2. Data on the numbers of drug users should be collected, for each specific drug account-
ing for multiple drug usage. This data will be important in looking for synchrony
of drug epidemics over the different provinces and possible periodicity in drug use
patterns.
All these will help in better understanding of drug use patterns and designing proper
control and rehabilitation strategies.
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